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BARTONELLA HENSELAE INHIBITS CELLULAR APOPTOTIC REGULATORS TO
ENSURE SURVIVAL
By

JEFFERY TODD PARKER

Under the Direction of Barbara R. Baumstark

ABSTRACT

Human pathogens survive anti-pathogen host immune assault by either circumventing or
evading the host immune response. Bartonella henselae, an intracellular pathogen previously
shown to disrupt intrinsic apoptotic messengers to enhance its survival, exploits multiple facets
of the cellular apoptotic mechanisms.
Cellular pathways affected by apoptotic processes were assessed using real-time reversetranscriptase-polymerase-chain-reaction (rRT-PCR) to measure the effect of B. henselae on cell
regulator gene expression (TRADD, FADD, caspase-8 and caspase-3), caspase activity, DNA
cell cycle analysis, cell regulator protein expression and overall cell viability and morphology.
The presence of B. henselae suppresses overall gene expression for TRADD and FADD and it
dramatically suppresses ceramide-induced TRADD and FADD gene expression. The presence of
B. henselae has a noticeable effect on ceramide-induced caspase-8 and caspase-3 gene
expression. Only caspase-3 enzymatic activity was ceramide-induced and likewise supressed by

the presence of B. henselae, whereas caspase-6 and caspase-8 were unaffected and equivalent to
controls. The presence of B. henselae inhibits ceramide-induced DNA fragmentation, maintains
overall cell morphology and enhances host cell viability. Lastly, B. henselae inhibits the timedependant ceramide-induction of TRADD protein and suppresses ubiquitous FADD protein
expression.
We demonstrated that B. henselae inhibits apoptotic induction in a systematic manner
following exogenous apoptotic induction. B. henselae protection of microvascular endothelial
cells from apoptosis induction begins at the modulation of cell surface receptor-dependent
signaling. B. henselae minimizes, but does not completely abrogate, the cytotoxic effect of the
apoptogenic shingolipid ceramide on human microvascular endothelial cells (CDC.EU.HMEC1).
Broadening our understanding of the sequence of cell regulator suppression events by
intracellular pathogens will provide insight into disease manifestation. Further, understanding
how infected cells initiate and conclude apoptosis will open new avenues into the study of
disease treatment.
INDEX WORDS: Bartonella henselae, Apoptosis, Ceramide, TRADD, FADD, Caspase, Realtime RT-PCR
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CHAPTER 1
GENERAL INTRODUCTION

Overview
Cell death is an essential process in the growth and maintenance of all multicellular
organisms. Cells are constantly being replaced as they age or become damaged. Since the human
body typically produces about 10 billion new cells each day, it must have some way to rid itself
of senescent, functionally impaired, or otherwise unwanted cells. One way to accomplish this is
through apoptosis.
Apoptosis is a well-ordered process of programmed cell death. Cells undergoing
apoptosis show a distinct set of morphological changes, including shrinking of the cytoplasm,
condensation of chromatin in the nucleus, and membrane blebbing. The last stages of apoptosis
are accompanied by the disintegration of the cell into small vesicles called apoptotic bodies.
Apoptotic processes play a number of beneficial roles during the life cycle of the organism,
including the removal of infected and neoplastic cells, and the elimination of superfluous cells
during differentiation and development. Apoptotic processes have also been implicated in the
cellular destruction associated with a number of disease states, including Parkinson’s Disease
(Schulz 2008), Alzheimer’s Disease (Dickson 2004), and AIDS (de St Groth and Landay 2008).
The highly structured mechanisms underlying apoptotic processes can be distinguished
from necrosis, a form of death resulting from direct injury to the cell. Necrosis involves the
release of degradative lysosomal enzymes into the cytoplasm, where they cause massive
destruction of cellular components. Cell lysis then ensues, resulting in the release of harmful
chemicals into the proximal extracellular environment. This in turn induces an inflammatory
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response, precipitating the destruction of surrounding tissues. In contrast, cellular debris
accumulating in the late stages of apoptosis is rapidly ingested by tissue macrophages in a
manner that does not induce the inflammatory response (Moreira and Barcinski, 2004). The
signal for phagocytic ingestion of apoptotic bodies is the translocation of phosphatidyl serine
(PS) from the inner to the outer leaflet of the plasma membrane (Figure 1). The process by which
PS is moved to the external surface of the cell is not fully understood, but its role as a marker
triggering phagocytic digestion allows apoptotic bodies to be eliminated without eliciting the
inflammatory responses that cause damage to nearby cells (van England et al., 1998).

Apoptosis Pathways of Induction
There are two general mechanisms of apoptotic induction. The extrinsic pathway, as its
name implies, is triggered by a signal from outside the cell. Specific signaling ligands initiate the
apoptotic sequence by interacting with a transmembrane receptor located on the cell surface.
Trimerization of this receptor in response to ligand binding then precipitates a cascade of events
that leads to the sequential activation of several cysteine-aspartate-specific proteases (caspases).
Activated caspases degrade cellular components directly or indirectly through their proteolytic
activation of other cellular proteases. Induction of the caspase cascade results in the eventual
death of the cell (Salvesen and Dixit 1999). The intrinsic pathway is induced by internal
stressors, such as DNA damage, heat shock, or by products of the extrinsic pathway. The
intrinsic pathway involves the permeabilization of mitochondrial membranes and the resulting
release of mitochrondrial proteins into the cytoplasm, where they set in motion a caspase cascade
that eventually merges with that of the extrinsic pathway (Giacca 2005).
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Figure 1 Phosphotidylserine Translocation. Translocation of phosphotidyl serine (PS) is an
early indicator of apoptosis. Following apoptosis induction, PS translocates to the outer
membrane and marks the cell for ingestion by phagocytic cells.

The Extrinsic Pathway
The initial stages of extrinsic induction have been well characterized, and are mediated by
the action of several tumor necrosis factors (TNF), or “death receptors”. Tumor necrosis factor
(TNF) receptors are members of a superfamily of membrane-spanning proteins that includes
TNF-receptor-1 (TNFR1), TNF-receptor-2 (TNFR2) and Fas (Ware, 2003). Activation of the
TNF receptors is believed to occur when a trimerized ligand such as FasL or TNF-α induces the
trimerization of three TNF receptor monomers at the cell surface (Dempsey et al., 2003). TNF
receptor proteins contain a highly conserved 80-amino-acid region that is localized to the
cytoplasmic side of the membrane (Thorburn, 2004). This region of the protein is referred to as
the “death domain” (DD). Through interactions between their death domains, trimerized TNF
receptors cluster together in lipid rafts (ceramide-rich regions of the plasma membrane) to form a
signal transduction complex (Grassme et al., 2003; Ruvuolo, 2003). The receptor trimers attract
specific adaptor proteins that bind to the receptors through their own DD sequences (Walsh et
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al., 2003). Adaptor proteins in turn recruit procaspase-8 (an “initiator” caspase) to the TNFreceptor complex, acting directly or indirectly through a second adaptor protein. Binding by
procaspase-8 to the adaptor protein occurs at a region of homology shared by the two proteins
called the Death Effector Domain (DED). Association of receptor, adaptor(s), and procaspase-8
produces a complex on the membrane called the Death Inducing Signaling Complex (DISC;
Ashkenazi and Dixit, 1998).
The process of DISC formation can be illustrated by the interactions between TNFR1 and
its adaptor proteins. Following binding of the ligand to the receptor, TNFR1 trimers form a
complex with the adaptor molecule TRADD (TNF-receptor-associated death domain) through
interactions between the death domains of the two proteins. TRADD in turn recruits a second
adaptor molecule, FADD (Fas-associated death domain), which also binds to TRADD through
DD interactions (Green, 2003). The DED region of FADD then interacts with the homologous
region of procaspase-8; (Thorburn et al., 2003) to form the DISC (Figure 2). Procaspase-8 exists
within this complex as a dimer and undergoes a process of self-activation. Activated caspase-8
subsequently recruits and activates an “executioner” caspase (caspase-3), and this process sets in
motion a cascade that ultimately results in the digestion of about 100 proteins (Creagh et al.,
2003).

Caspase-8 Activation
Caspases function as “messengers” by relaying apoptotic signals from adaptor proteins to
cellular target proteins. To prevent unscheduled cell suicide, each caspase is translated as a
zymogen containing a pro-domain and a catalytically active domain (Green, 2003; Boatright and
Salvesen, 2003). Early studies on the mechanism of caspase-8 activation revealed that the two
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procaspase-8 molecules recruited to the DISC are able to undergo cross-proteolysis in trans, with
one digesting the other (Zimmerman and Green, 2001). This caused investigators to equate
activation with autoproteolysis, and led them to propose that proteolytic cleavage is an essential
component of the caspase-8 activation process (Shi, 2002).

B.

A.
Receptor ligand

Receptor ligand
TNF receptor

TNF receptor

DD

DD
DD
DD

C.

TRADD

D.

Receptor ligand

Receptor ligand
TNF receptor

DD
DD
DD
DD

TRADD
FADD

DED

TNF receptor

DD
DD
DD
DD
DED
DED

TRADD
FADD
Procaspase-8

Figure 2: DISC formation at TNFR1.

Figure 2. Formation of the TNF-receptor Death-inducing-signaling-complex (DISC). The
trimeric ligand trimerizes the TNF receptor (A). The trimeric receptor recruits the primary
adaptor protein, TRADD (B). The primary adaptor recruits the secondary adaptor protein, FADD.
Interaction of adaptors is through the Death Domain (DD) of the adaptor proteins (C). The
Death-Effector-Domain (DED) of the secondary adaptor protein interacts with the DED of the
recruited initiator caspase, procaspase-8 (D).

However, the results of more recent studies suggest that proteolysis is not in itself necessary for
the generation of caspase-8 activity (Thorburn 2004). This conclusion is based on investigations
into the role played by naturally occurring inactive caspase-8-like molecules in the regulation of
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death-receptor induced apoptosis. These regulatory molecules are called cellular FLICE-likeinhibitory proteins, or c-FLIP. FLICE stands for FADD-like-interleukin-converting-enzyme, the
name previously assigned to caspase-8 (Day et al., 2006). .
c-FLIP proteins can exist in two isoforms, a long form (c-FLIP-L) and a short form (cFLIP-S). c-FLIP-L contains two DED domains plus a region homologous to the catalytic domain
of caspase-8 (Kataoka 2005). c-FLIP-S also contains two DED domains, but lacks the caspase-8
catalytic domain region. c-FLIP-L can dimerize with caspase-8, but is not an active protease
because it contains several sequence differences that affect the catalytic domain of the protein
(Longley et al., 2006).
By interacting through their DED regions with adaptor molecules such as FADD, c-FLIP
proteins compete with procaspase-8 for binding at the DISC (Figure 3). Based on this
observation, c-FLIP proteins were initially believed to act solely as inhibitors of apoptosis.
Subsequent evidence, however, suggested that under certain circumstances the recruitment of cFLIP-L to the DISC can actually promote apoptosis by activating caspase-8 (Sohn et al., 2006).
Recent studies have demonstrated that the formation of a heterodimer between c-FLIP-L and
procaspase-8 is enough to induce caspase-8 activity, even though c-FLIP-L is unable to catalyze
the cross-proteolysis of its partner. This has led investigators to conclude that caspase-8 is
enzymatically active in its unprocessed form. Processing may stabilize the caspase-8 dimer, but is
neither necessary nor sufficient for catalytic activation (Boatright and Salvesen 2003; Salvesen
and Dixit 1999; Zimmerman and Green 2001).
The demonstration that dimerization alone is sufficient for caspase-8 activation has raised
questions as to the role of processing in caspase-8 activity. Recent evidence indicates that
caspase-8 is recruited to the cytosolic complex of TRADD and FADD (Micheau and Tschopp,
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2003). The caspase-8 dimer is capable of self activation by cleavage of internal residues. Within
the cytosol the processed caspase-8 is available to interact with substrates in close proximity
(Harper et al., 2003).

(A).

(B).

Trimerized
receptor

TRADD

Receptor
ligand

DD

DD

DD
DD

DD
DD

DD
DED

DD
DED

FADD

c-FLIP-L

c-FLIP-L

DED CAT DED

DED CAT DED
DED

Caspase-8

DED
DED

INACTIVE
CASPASE 8
DED

ACTIVE
CASPASE 8

Figure 3. c-FLIP L Is a Caspase-8 Antagonist and/or Activator. The long form of cellular
FLICE-like inhibitory protein c-FLIP L interacts with FADD and Caspase-8. (A). c-FLIP L
dimerizes with caspase-8 (proform), inducing its activation. (B). c-FLIP L competes with
caspase-8 for FADD death-effector-domain (DED).

Activation of Other Caspases
Following its activation, caspase-8 cleaves caspase-3, setting off a cascade of proteolytic
events that result in the activation of several downstream caspases. Once activated,
“executioners” caspases such as caspase-3 (Feng, Y. et al., 2005), caspase-6 (MacLachlan and
El-Deiry, 2002) and caspase-7 (Xia, Y. et al., 2007; Slee et. al., 2001) cleave key cellular
components, thereby precipitating cell death. Each executioner caspase can exist as an inactive
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dimer in its zymogen form. The executioner caspases reside primarily in the cell cytosol.
Caspase-3 is the most abundant caspase in the cytosol, and acts as an executioner for both
extrinsic and intrinsic pathways (Chickova et al., 2004). Caspase-3 cleaves caspase-6 and polyADP-ribosyl polymerase as well as other cellular proteins. Activation of these targets ultimately
leads to the cleavage of lamin proteins and the fragmentation of nuclear DNA (Hirata et al.,
1998).

The Intrinsic Pathway
As mentioned previously, internal cellular stress such as DNA damage or oxidative stress
can act as a trigger for apoptosis. The response to internal stress is mediated by the intrinsic
pathway. Intrinsic induction of apoptosis leads to an increased permeability of the mitochondrial
outer membrane, which results in the release of cytochrome c and other mitochondrial proteins
that trigger a caspase cascade. Regulation of membrane permeability is achieved by members of
a large protein superfamily called Bcl-2, derived from B-Cell Lymphoma, the cell lineage from
which it was originally identified (Yang et al., 1997). Included within the Bcl-2 superfamily are
proteins that stimulate apoptosis (pro-apoptotic proteins) and those that suppress it (antiapoptotic proteins; Cory and Adams, 2002). All Bcl-2 family members share one or more of four
BH (Bcl-2 Homology) domains that promote protein-protein interactions and are required for
protein function. Anti-apoptotic proteins contain all four domains (BH1 – BH4), while proapoptotic proteins contain from one to three domains (Cory et al., 2003).
Induction of the intrinsic pathway begins with a disruption of the balance between proand anti-apoptotic factors. The two primary anti-apoptotic proteins, Bcl-2 and Bcl-XL, are located
in the outer membrane of the mitochondria. Two additional Bcl-2 family members, Bax (Bcl-2
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associated X protein) and Bak (Bcl-2 homologous antagonist/killer protein), also reside in the
mitochondrial membrane (Figure 4). Based on their resemblance to bacterial pore forming
channel proteins, Bax and Bak are believed to be involved in production of the pores through
which mitochondrial components are leaked into the cytoplasm (Desagher et al., 1999). Thus,
they play a pro-apoptotic role within the cell. There are also several cytoplasmic pro-apoptotic
proteins that act as sensors of cellular stress. These proteins typically contain only the BH-3
homology domain, and therefore are sometimes referred to as BH-3-only proteins. If they are
activated by apoptotic signals, they travel to the surface of the mitochondria where they interact
with membrane-associated Bcl-2 family members (Ashkenazi, 2008).
The BH3-only proteins can be divided further into three subgroups. One group,
represented by proteins such as Bim (Bcl-2 interacting mediator of cell death), can bind directly
to the pro-apoptotic proteins Bax and Bak, activating them to produce pores in the membrane.
The second group, represented by proteins such as Bik (Bcl-2 interacting killer protein) and Bad
(Bcl-2 associated death promoter), are believed to exert their effect primarily by binding to antiapoptotic proteins such as Bcl-2 and Bcl-XL (Bcl-2 extra-long protein) (Ashkenazi, 2008). In
this way, they displace other pro-apoptotic proteins that might be bound to the anti-apoptotic
proteins, thereby freeing proteins such as Bax and Bak to oligomerize with each other and form
pores. The third group, represented by Bid (BH3 Interacting Domain death agonist), can induce
pore formation through direct binding to Bak/Bax or through binding to the anti-apoptotic
proteins (Goping et al., 1998). The mechanism of action of the pro-apoptotic protein Bid (Figure
5) provides a well-documented example of the steps leading to induction of the intrinsic pathway,
and illustrates how the apoptotic switch depends on a delicate balance between the pro- and antiapoptotic proteins at the mitochondrial membrane (Lessene et al., 2008).
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Under non-apoptotic conditions, Bid is located in the cytosol in its inactive form (Tang et
al., 2000). In response to cellular stress, however, Bid can be activated by caspase-8, which
cleaves it into a truncated form known as tBid (Ogretum and Hannun, 2004). tBid then migrates
to the surface of the mitochondrion, where it interacts directly with Bak, causing the protein to
undergo a conformational change that induces Bax/Bak pore formation (Cory et al., 2003). In
addition to its effect on Bak, tBid can also interact with anti-apoptotic proteins such as BclXL. If
the anti-apoptotic proteins are in excess, they can bind to tBid, thereby sequestering it so that it
cannot interact with and activate Bak; conversely, if tBid is in excess, it can inactivate antiapoptotic proteins and directly activate Bak simultaneously.
TNF-R1

FAS

PP2A

DD

c-FLIP

DD
TRADD
DD

FADD

DD
FADD
DED

FAF

DD
PKA

PI3K

Microtubule damage
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Akt/PKB

Raf1
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CASPASE-8
CASPASE-8

Bim
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x

Bcl-2
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x

Bcl-2
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cIAP

Bak
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BH3

CASPASE-3

Caspase-9
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Apoptosis
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Cyto-c
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DNA Fragmentation

Figure 4. Intrinsic Apoptosis Pathway. The intrinsic pathway demonstrates the interaction of
the caspase cascade and the bcl-2 proteins. Mitochondrial proteins interplay in the formation of
the apoptosome leading to activation of executioner caspase-3. Image adapted from
www.proteinlounge.com
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It has been reported (Grinberg et al., 2002), that a mutant Bid that lacks a functional BH3
domain is still able to induce cyctochrome c release and apoptosis in the absence of direct
interactions with either Bak or the Bcl-2 anti-apoptotic proteins. To explain these observations,
the investigators proposed the tBid forms homo-oligomers through a BH3-independent
mechanism to create pores in the mitochondrial membrane. Thus, it is possible that Bid plays
multiple roles in the apoptotic process.
Cytochrome c, a heme-binding protein that is loosely associated with the inner
mitochondrial membrane, is an integral component of the mitochondrial electron transport chain.

Cellular stress

Bid

tBid
Caspase 8

Bcl-XL

Prevents activity of
Pro-apoptotic factors

Bax/Bak

Activates pore
formation

Release of Cytochrome c

Figure 5. Mechanism of Action of Bid. Bid is activated by caspase-8 cleavage to generate the
truncated (t-Bid) form. tBid can interact with both anti-apoptotic proteins (Bcl-XL) or proapoptotic proteins (Bax/Bak). Excess of Bcl-XL will lead to sequestering of tBid. Excess of tBid
leads to inactivation of Bcl-XL and activation of Bax/Bak.
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With the destruction of mitochondrial membrane integrity following an apoptotic stimulus,
however, cytochrome c is quickly released into the cell cytosol (Kluck et al., 1997; Yang et al.,
1997), where it binds to and activates APAF-1 (apoptosis protease activating factor-1), a receptor
protein located at the outer mitochondrial membrane. The APAF-1/cytochrome c complex then
associates with dATP to form a complex called the apoptosome (Wang, 2001). The caspase
recruitment domain (CARD) of APAF-1 recruits caspase-9 to the apoptosome complex
(Rodriguez and Lazebnik, 1999). Apoptosome-bound caspase-9 initiates the activation of
terminal effector proteins (e.g., caspase-6) through the cleavage and activation of other
executioner caspases (caspase-3 and -7) (Tao et al., 1998). Through its proteolytic activation of
caspase-3, caspase-9 initiates the cleavage of multiple cellular targets, which ultimately results in
an orderly disintegration of the cell (Wang, 2001; Nakazawa et al., 2003). However,
mitochondrial induced apoptosis does not necessarily require caspase-9 (King, 2005).

Ceramide and Ceramide Signaling
Ceramides are lipid molecules consisting of sphingosine and a fatty acid. They constitute
part of the structure of sphingomyelin, one of the major components of the lipid bilayer, and as a
consequence are present in high amounts in the plasma membrane. The classic cell membrane
model, originally depicted by Singer (Singer and Nicholson, 1972), proposes a random
distribution of lipids and proteins in the cell membrane. However, recent studies indicate that
the lipid distribution in the cellular membrane is anything but random. Until recently, ceramides
were believed to function predominantly as structural components in the membrane. In the past
few years, however, a number of studies have revealed that these compounds also play a role in
cell signaling, participating in several processes, including cell differentiation, cellular
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senescence, and the growth of cancer cells (Browne and London, 1998). Moreover, it is
becoming increasingly evident that ceramides play a pivotal role in apoptosis (Davis et al.,
2006).
It has been shown that clustering of Fas and members of the TNF receptor superfamily
triggers the conversion of sphingomyelin into ceramide (Gulbins and Li, 2006). The newly
generated ceramide then becomes a major component of the lipid rafts that serve as the anchor
points for the association of TNF receptors and other proteins with pro-caspase-8 to form the
DISC complex used in the extrinsic apoptotic pathway. Recent studies also demonstrate that
ceramide is essential for the formation of these lipid rafts. In doing so it serves as an essential
signaling component for the aggregation of receptor death domains (Gulbins et al., 2000;
Grassme et al., 2001). Ceramide also plays a role in the intrinsic apoptotic pathway by
activating the kinase suppressor of Ras (KSR). Activation of KSR initiates a phosphorylation
cascade that ultimately inhibits Akt, a kinase whose substrates include the Bcl-2 pro-apoptotic
protein Bad (Datta et al., 1997; Schubert et al., 2000). Phosphorylation by Akt converts Bad into
its inactive form. Thus, the indirect inhibition of Akt by ceramide leads to the accumulation of
unphosphorylated, active Bad at the mitochondrial membrane, and thereby promotes cell death
(Basu et al., 1998).
Ceramides are classified by the length of their fatty acid chains. Natural ceramides
typically have fatty acid chains of ~16-carbon atoms. Cultured cells are permeable to exogenous
short-chain (two to six carbons) ceramides, but are not permeable to longer carbon chain
molecules. Still, ceramides greater than six carbons can translocate between the leaflets of the
cells plasma membrane. Exogenously supplied ceramides mimic their natural analogues to
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induce anti-proliferative responses, cell-cycle arrest, differentiation, and apoptosis (Obeid et al.,
1993).
Exogenously added C2-ceramides have been reported to increase the permeability of
mitochondrial membranes. However, it can also induce NFκB, which subsequently induces a
number of genes responsible for cell survival (Ruvulo, 2001). In cells of cancer origin, C2ceramides lead to transient caspase-3 activation following 24 hours of ceramide treatment (Fillet
et al., 2003). The mode and severity of cellular response to ceramide are cell type specific.

Bartonella and Host Cell Survival
Bartonella henselae is the causative agent of Cat-Scratch Disease (CSD), an illness
characterized by low-grade fever, malaise, and swelling of the lymph nodes (Emmons et al.,
1976). The bacterium is usually transmitted through the bite or scratch of an infected cat or
kitten. Symptoms appear between one and two weeks after infection (Bass et al., 1997). In many
patients, a small cutaneous lesion is noted at the site of the bite or scratch a few days after the
injury (Slater et al., 1993). B. henselae infects endothelial, epithelial, erythrocyte and
macrophage cells in cats and humans (Minnick and Anderson, 2000; Kempf et al., 2005). In
immunocompetent individuals, CSD is typically a self-limiting disease, lasting from six to 12
weeks. In contrast, immunocompromised individuals such as AIDS patients can be persistently
infected by B. henselae. Persistent B. henselae infection can trigger endothelial cell proliferation,
resulting in Bacillary Angiomatosis (BA). Patients with BA have multiple vasculoproliferative
lesions on their skin. Vascular tumors can also appear in response to organ infection, a process
known as Bacillary Peliosis (BP). The bacterial factor(s) responsible for this proliferation have
not been fully characterized, although they are known to be proteinaceous and require bacterial
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synthesis following infection (Maeno et al., 1999; Dehio 2003). Upon infection of endothelial
cells, the bacteria induce the formation of an adhesion-molecule-rich cell membrane protrusion
called an invasome (Dehio 1999).
The formation of the invasome is an actin-dependent and microtubulin-independent
process. Aggregated bacteria are trapped in the actin and phosphotyrosine-rich tips of the
protrusion and drawn into the cell (Figure 6). The tips of the invasome are also enriched in caps
of intracellular adhesion molecule-1 (ICAM-1) and other adhesion molecules (Dehio, 2003).
Gene expression of most adhesion molecules, including ICAM-1, VCAM-1 and ELAM-1
molecules is regulated by the nuclear factor NF-κB (Clifton et al.1998; True et al., 2000).
Vascular endothelial cells either ubiquitously express or are induced to express adhesion
molecules following cytokine treatment (Ades et al., 1992). In addition to adhesion molecules,
NF-κB regulates cell proliferation factors including vascular endothelial growth factor, VEGF
(Kirby 2004; Kempf et al., 2001).
Enhanced expression of host-encoded growth factors via a paracrine loop has been
demonstrated following B. henselae infection of several cell types. The presence of the bacteria is
not necessary for either enhanced endothelial cell proliferation or enhanced growth factor
expression but direct contact between B. henselae and endothelial host cells does potentiate an
enhanced proliferative effect (Fuhrmann et al., 2001). Growth factor expression is not sustained
indefinitely following intracellular B. henselae infection (Kempf et al., 2002).

Bartonella and Apoptosis Suppression
Obligate intracellular pathogens, particularly viruses, often ensure their survival by either
promoting host cell proliferation or by preventing the induction of programmed cell death (Lax
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and Thomas, 2002; Mehock et al., 1998; Hentschel et al., 2000; Saini et al., 1999). It has been
shown previously that B. henselae infection upregulates cell surface adhesion molecule
production and suppresses activity of both initiator and executioner caspases (Kirby and
Nekorchuk, 2002). The upregulation of vascular cell endothelial growth factor (VEGF) and
secretion of other apoptosis inhibitory proteins is considered to be the principal anti-apoptotic
mechanism used by Bartonella (Kempf et al., 2005).

Recently, Bartonella encoded anti-

apoptotic substrates have been described (Schmid et al., 2004; Schmid et al., 2006). Our studies
were designed to investigate the multifaceted manner by which B. henselae exerts an antiapoptotic effect by modifying both molecular expression and protein expression/activation of
both extrinsic and intrinsic apoptosis modulators.

Figure 6. Invasome. The “invasome” is characterized by membrane protrusions which entrap an
aggregate of bacteria. The invasome facilitates B. henselae invasion of endothelial cells through
adhesion molecule rich membrane protrusions (reproduced with permission, Cristoph Dehio).
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Summary
The mechanisms whereby B. henselae establishes and maintains a successful infection
have not been fully characterized. However, it has been demonstrated that neither host cell
growth nor a paracrine loop of endogenous growth factors are the sole mechanisms for ensuring
B. henselae intracellular survival (Anderson, 2001; Resto-Ruiz et al., 2002). The reports that B.
henselae affects the expression of genes that are known to be involved in cell death suggest that
this bacterium may use an additional survival mechanism: the prevention of apoptotic processes
that would ultimately lead to the death of its host cell. Activation of cell growth and suppression
of apoptosis are two seemingly opposite pathways with the same net effect. This study addresses
the observations that B. henselae ensure its survival by processes that extend beyond a simple
manipulation of cell proliferation. Rather, B. henselae preserves its safe haven by inhibiting the
initial intrinsic apoptotic pathway and, further, preventing the induction of executioner caspases
targeted by the apoptogenic agent C2-ceramide. The cellular factors inhibited by B. henselae
provide a comprehensive restraint on the intrinsic apoptosis pathway modulators.
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CHAPTER 2
BARTONELLA HENSELAE INHIBITION OF APOPTOSIS MODULATORS

Introduction
Intracellular pathogens and tumor cells enhance their ability to survive by circumventing
host apoptosis. Tumor cells accomplish this by inducing the over-expression of anti-apoptotic
proteins, such as Bcl-2 (Apakama et al., 1996). However, pathogens first mitigate the immune
assault against them before successfully infecting the competent host cells. The tropism of B.
henselae for endothelial cells is an intriguing evolutionary adaptation due to 1.) the presence of
Gram negative bacterial LPS on B. henselae, 2.) the endothelial cell role in excreting TNF-α
following exposure to bacterial LPS and 3.) the endothelial cell expression of NF-κB genes
following paracrine-loop exposure to TNF-α (Dehio, 2001; Kyong-Bok et al., 1998; Imaizumi et
al., 2000). B. henselae seems to exploit all of these features to permit the tropism for an
intracellular safe haven in microvascular endothelial cells.
To ensure chronic intracellular infection, B. henselae is capable of inhibiting apoptosis.
Our study was designed to investigate the ability of B. henselae to inhibit apoptosis following
direct apoptogenic challenge. A variety of apoptogenic agents were screened for their ability to
induce apoptosis. Among these agents were camptothecin, staurosporine, C2-ceramide, ricin
toxin and abrin toxin. The mode of action of these agents spans protein kinase activation,
inhibition of protein kinase DNA binding, inhibition of DNA packaging enzymes and inhibition
of ribosomal activity. We chose C2-ceramide not only because it was capable of inducing dose
dependent apoptosis, but also because it mimics the mechanism of LPS induced inflammatory
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pathways. The addition of C2-ceramide alters the membrane bilayer to induce the formation of
lipid rafts.
Table 1. Apoptogenic Agents.
Mode of action
TNF-α

C2-ceramide

Staurosporine

Camptothecin

Induces extrinsic apoptosis pathway,
causes release of in vivo ceramide

Effect on HMEC-1 cells
Ineffective with HMEC-1

Increases protein kinase activity

Concentration and timedependent morphological
effect

Inhibition of protein kinase ATP binding

Required high
concentration before
effective

Quinoline alkaloid inhibits DNA
topoisomerase I

Low concentration
obliterated cells, media
cloudy

ET-18
(etoposide)

Topoisomerase II inhibitor

Low concentration
obliterated cells, media
cloudy

Ricin toxin

Depurination of eukaryotic ribosomal
sarcin-ricin loop

Effective at low
confluency and low serum

Abrin toxin

Depurination of eukaryotic ribosomal
sarcin-ricin loop
Varied: G0/G1 cycle arrest,
downregulation of
ERK2 activity

Effective at low
confluency and low serum

Serum
starvation

≤5% serum has "serum
starvation effect"

A variety of apoptogenic agents were tested for their ability to induce apoptosis. Mechanism of
apoptosis for agents tested was varied. Agents were tested on uninfected cells for 4 hours
incubated at 35oC at 95% humidity.

Lipid raft formation provides a mechanism for intrinsic apoptosis pathway receptors to
cross link, thereby initiating the intrinsic apoptosis pathway. The presence of B. henselae
interferes with the C2-ceramide stimulated expression of intrinsic pathway proteins such as TNF-
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associated death domain (TRADD) and Fas-associated death domain (FADD) inhibiting the
initiating stage of apoptosis induction. Further, the presence of intracellular B. henselae inhibits
C2-ceramide stimulated expression of caspase proteins and caspase enzymatic activity. Lastly, the
presence of B. henselae inhibits DNA fragmentation and the protective effect attributed to the
bacteria is visible by changes in gross cellular morphology.

Materials and Methods
Western Blot
HMEC-1 cells were lysed using PBS-TDS (0.01M PBS with 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS, 1% protease inhibitor cocktail (Pierce, Rockford, IL; Burnette,
1980). Twenty micrograms of cell lysates were mixed 1:5 with 5X Loading Buffer (Bio-Rad,
Richmond, CA). Cell lysates were loaded using an SDS-PAGE precast (12% resolving gel, 4%
stacking gel) minigel system (Bio-Rad, Richmond CA). Gels were run at 20 mA following
dilution of 10X Tris/Glycine/SDS Buffer (Bio-Rad, Richmond, CA). Proteins were transferred
onto Immuno-Blot PVDF Membrane (Bio-Rad, Richmond, CA) at 250 mA for 1 hour.
Blot membranes were blocked using 10X Blocking Agent (Bio-Rad, Richmond, CA) in
TBS overnight at 4oC. PVDF membranes were incubated with primary Rabbit anti-FADD
antibody (Santa Cruz) at 1:1000 in Blocking Buffer for 1 hour at room temperature while shaking
gently. Blots were washed 3x 10 minutes in Wash Buffer (TBS supplemented with 0.1% Tween
20). Blots were incubated with phosphatase-labeled anti-Mouse IgG (H+L) secondary antibody
(KPL, Gaithersburg, MD) at 1:10,000 in Blocking Buffer for 1 hour at room temperature while
shaking gently. Blots were washed 3x 10 minutes in Wash Buffer while shaking. Blots were
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developed by incubating for 10 minutes with PhosphaGLO Reserve AP Substrate (KPL,
Gaithersburg, MD). Excess substrate was drained and blots were inserted into a plastic sheet
cover. Blots were visualized using a Bio-Rad documentation System.
Bacterial Culture
Bartonella henselae 882-str was cultured on Brain Heart Infusion (BHI) agar
supplemented with 5% rabbit blood and 50 μg/mL streptomycin (Invitrogen, Carlsbad, CA). To
obtain pure cultures of B. henselae, bacterial cultures were streaked for isolation and allowed to
grow for 3 days at 37 oC and 5% CO2. Cultures used for infection were prepared by streaking B.
henselae onto a plate of BHI with 5% rabbit blood and 50 μg/mL streptomycin (Lee and Falkow,
1998).
Cultures were grown for 3 days post-inoculation to ensure that log-phase bacteria were
used for all experiments. The zone of inoculum was scraped with a 10 μL loop and resuspended
in BHI broth. Bacterial cells were resuspended to an O.D.600 of 0.5, an optical density that
corresponds to approximately 1×109 cfu/mL. The concentration of bacteria was determined by
triplicate plate counts of serial bacteria dilutions, as described previously (Kirby and Nekorchuk,
2002).
Cell Culture
CDC.HMEC-1 (HMEC-1) cells were obtained by Material Transfer Agreement (F.J.
Candal, E.W. Ades, CDC, Atlanta, GA; T. Lawley, Emory University, Atlanta, GA.). HMEC-1
endothelial cells were grown at 37 oC and 5% CO2 using MCDB-131 (GIBCO BRL) media
supplemented with 15% fetal bovine serum (Hyclone, Ogden, UT), 25 μg/mL streptomycin and
1% L-glutamine (Invitrogen, Carlsbad, CA). HMEC-1 cells were seeded at 1.5×105 cells/mL for
both stock subcultures and experimental cultures. HMEC-1 cells were grown for 3 days to 70%+
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confluency prior to experimental use. Cells were subcultured every 7 days or as needed. For
optimal performance and stability, HMEC-1 cells were used at passages T16 to T25.

Chemicals and Antibodies
C2-ceramide (N-acetyl-D-erythrosphingosine) was dissolved in absolute ethanol at a
concentration of 20 mM (Avanti Polar Lipids, Alabaster, AL). Murine anti-human TRADD and
FADD were obtained from BD/Pharmingen (San Diego, CA). Secondary 488 conjugated goat
anti-mouse IgG was obtained from Molecular Probes (Eugene, OR). Staurosporine and
camptothecin were obtained from Sigma (St. Louis, MO). RNAase H was obtained from
Epicentre (Madison, WI).
Ricin and abrin toxin were prepared from whole beans. One gram of beans was macerated
to generate pulp mass and expressed toxin “mother liquor.” PBS (0.01M, pH 7.2-7.4) was added
to provide 1 mL of aqueous phase. Total material was centrifuged for 3 minutes at 3000 xg at
25oC. The aqueous phase was decanted and centrifuged again for 3 minutes at 3000 xg at 25oC.
The respective toxins were semi-quantified using CDC LRN immunoassays for the detection of
ricin or abrin toxin compared to a known toxin standard.
Intracellular Infection with B. henselae and Ceramide Treatment
HMEC-1 cells were grown to 70%+ confluency prior to infection. B. henselae bacteria
were harvested and resuspended at 1×107 cfu/mL in serum-free MCDB-131 media (Invitrogen,
Carlsbad, CA). An absorbance of 0.5 at 600 nm yields 1×109 cells/mL (McCord et al., 2005).
The cell culture medium was replaced with reduced serum (3% serum) media prior to B.
henselae infection. HMEC-1 cells were infected at an MOI of 10 by adding 100 μL of a 1×109
cfu/mL bacterial suspension to HMEC-1 cells cultures approximately 70%+ confluent. HMEC-1

23
cultures were grown in 6-well Costar culture plates. B. henselae-infected cells were allowed to
incubate overnight and then media replaced with MCDB-131 supplemented with 15% FBS for
the remainder of the 36 hours at 37 oC and 5% CO2 (Liberto et al., 2003). C2-ceramide was added
to a total concentration of 20 μM to both B. henselae-infected and uninfected endothelial cells.
Uninfected and untreated cells were used as experimental controls.
Endothelial Cell Viability Assay
Cell viability was determined by Trypan Blue (Invitrogen, Carlsbad, CA) exclusion (Bird
and Forrester, 1981). Cells were harvested by collecting trypsinized cells following standard
trypsinization procedures. Trypsinized cells were briefly centrifuged for 3 minutes at 100 xg at 4
o

C. The supernatant from centrifuged cells was carefully aspirated to remove cellular debris.

Collected cells were resuspended in a minimal volume of 100 μL. Trypan Blue was added at a
1:1 ratio with resuspended cells and viability was determined by a standard protocol using a Seitz
cell counting chamber (Sigma, St. Louis MO).
Flow Cytometric Intracellular Protein Analysis
HMEC-1 endothelial cells were infected and treated with ceramide as described here.
Cells were harvested by gentle agitation with 100 μM glass beads (Corning Glass, Corning, NY)
as described here. Harvested cells were washed 2x with 0.01M PBS, pH 7.4, and pelleted by
centrifugation at 100 xg for 3 minutes. Pelleted cells were resuspended and fixed by adding 10%
EM-grade formalin (Polyscience, Warrington, PA) in 0.01M PBS, pH 7.4, to a final
concentration of 1.5% formaldehyde. Cells were incubated in fixative for 10 minutes at 4oC.
Fixed cells were washed 2x with 0.01M PBS, pH 7.4, and pelleted by centrifugation at 100 xg for
3 minutes. Cells were then resuspended and permeabilized in 1X Perm II solution (BD, San Jose,
CA) in 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) for 10 minutes at 4 oC (Belloc et al.,
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2000). Cells were washed 2x with FACS Wash Buffer (0.01M PBS, pH 7.4 (Invitrogen,
Carlsbad, CA) supplemented with 2% human AB+ serum (Irvine Scientific, Irvine, CA.) +
0.01% NaN3). Cells were pretreated with excess unlabeled anti-TRADD or FADD antibodies
(BD, San Jose) for 1 hour at 4 oC and washed 2x with FACS Wash.
Cells were stained using 0.5 μg/sample of anti-TRADD (BD, San Jose, CA), 0.5 μg of
anti-FADD (BD, San Jose, CA) in 0.01M PBS, pH 7.4 at 4oC overnight. Cells were washed 2x
with FACS Wash and centrifuged at 100 xg. Secondary Alexa 647 goat anti-mouse antibodies
(Molecular Probes, Eugene OR) were used at a working dilution of 1:5,000. Samples were
analyzed on a FACSCaliber cytometer (BD, San Jose CA), calibrated daily with Calibrite beads
(BD, San Jose) supplied with lasers operating at 488 and 633 nm (Krutzik and Nolans, 2003)
Data were acquired using the FL4 channel excited at 633 nm and 668 emission.
Caspase Enzymatic Activity Assay
Samples were analyzed for activity of caspase-3, 6 and 8 using TrupointTM Caspase
Assays (Perkin-Elmer, Boston, MA), according to the manufacturers’ protocol. Briefly, cells
were washed in the well 2x with physiological saline and lysed using a 1:10 dilution of 10X
Lysis Buffer. Cells were homogenized by rapid pipetting and collected into 1.7 mL eppendorf
tube. The caspase sample wells consist of 10 μL caspase-DTT Buffer, 5 μL (800 nmol/L) caspase
substrate and 5 μL cell lysate. Background wells consist of 15 μL caspase-DTT Buffer and 5 μL
caspase substrate (Karvinen et al., 2002). Lysates and caspase substrates were incubated at 37oC,
95% relative humidity for a minimum of 2 hours prior to reading. Caspase assays were read using
a Victor3 plate fluorometer at 615 nm according to the manufacturers’ protocol (Wallac, Turku,
Finland).
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Multicaspase Fluorescent Assay
To a 100 μL aliquot of cells (1x105/mL), 4 μL of 20X SR-VAD-FMK (Millipore/Guava)
reagent were added, and to each sample or control tube was mixed by gentle vortexing and
incubated for 1 hour at 37°C in 5% CO2 incubator. The cells were resuspended once during the
incubation period. Approximately 1 mL of 1X Apoptosis Wash Buffer (Millipore/Guava) was
added to each tube, vortexed and centrifuged at 300 to 400xg for 5 minutes to pellet the cells.
The supernatant was removed and the cell pellet was retained. The cells were washed twice more
as described. Each cell pellet was resuspended in 100 μL of 1X Apoptosis Wash Buffer
(Millipore/Guava). Approximately 50 μL of stained cells were air dried on glass slides. Slides
were examined directly using a Nikon fluorescent microscope with a 565 nm excitation and
615nm emission filter
Flow Cytometric DNA Cell Cycle Analysis
Cell supernatants were collected and pelleted by centrifugation at 100 xg for 3 minutes.
Pelleted cells were added to harvested cells described below. Cell monolayers were washed 2x
with 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) prior to harvesting. Cells were harvested
from culture plates by gentle agitation with 100 μM glass beads (Corning Glass, Corning, NY).
HMEC-1 cells were prepared for ethanol fixation by washing 2x with excess 0.01M PBS, pH 7.4
(Invitrogen, Carlsbad, CA) and centrifuged for 3 minutes at 100 xg. Cells were fixed by the
addition of 0.5 mL 70% ethanol (Pharmco, Brookfield, CT) in sterile deionized water
(Mediatech, Richmond VA).
Ethanol fixed cells were washed 2x with excess 0.01M PBS, pH 7.4 (GIBCO/BRL,
Grand Island NY) and centrifuged for 3 minutes at 100 xg. Following fixation, cells were
resuspended in 200 μL of 0.01M PBS, pH 7.4 (Invitrogen, Carlsbad, CA) with 2 μg/mL RNAse
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A (Epicentre, Madison, WI). Cells were incubated for 30 minutes at 37 oC, washed 2x with
excess 0.01M PBS, pH 7.4, and subsequently resuspended at approximately 1×106 cells/mL in
0.01M PBS, pH 7.4, containing 5 μg/mL propidium iodide (PI, Sigma, St. Louis, MO.). DNA
cell cycle analysis was performed on a FACSCAliber (Becton-Dickinson, San Jose, CA). DNA
cell cycle data were assessed by log range FL-2 height for PI staining (Abraham et al., 2003).
Statistics
The data presented herein are the means± S.D. of three independent experiments with
experimental samples performed in triplicate. Statistical significance was determined using the
Student’s “two-tailed” t-test. A P value of <0.05 was considered significant.

Results
Analysis of FADD by Western Blot
Western blot analysis of Fas-associated Death Domain (FADD) was conducted to
determine whether B. henselae altered FADD protein expression. By two hours post-infection,
the levels of FADD are undetectable (Figure 7). From these observations, we conclude that there
is a significant and rapid decline in FADD protein expression during the course of B. henselaeinfection relative to their uninfected counterparts.
Apoptogenic Agents
Apoptogenic agents were tested for their ability to alter cell viability following 3 hours’
treatment of HMEC-1 endothelial cells. Apoptogenic agents were serially diluted and cell
viability determined using Trypan Blue exclusion for HMEC-1 cells grown at 4oC and 95%
humidity. Percent viability is presented in Figure 8. Among the apoptogenic agents tested, only
C2-ceramide was cytotoxic in a titratable dose-dependent manner. Further, several of the other
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30.6 kDa
17 kDa
MW Ctrl

1 hr

2 hr

Figure 7. FADD Western Blot. HMEC-1 cells were incubated with B. henselae for 1 hr at
37oC. Growth media was added and cells were harvested at 1 and 2 hour post-infection
timepoints. Control cells were harvested at timepoint of 2 hour post-infection identical
manner in the absence of B. henselae.

agents tested were cytotoxic, but did not produce the distinguishable morphological effects on
the endothelial cells that are characteristic of apoptosis (data not shown). For these reasons, C2ceramide was the apoptotic agent of choice for all subsequent experiments involving the
induction of apoptosis.
Cellular Morphology under Apoptotic Conditions
To determine the response of cells infected with B. henselae to signals inducing
apoptosis, we compared the effect of infection on HMEC-1 cells that were treated with ceramide
for varying periods of time. Prior to ceramide treatment, uninfected and B. henselae-infected cells
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Figure 8. Cytotoxic Effect of Apoptogenic Agents. Commercially available apoptogenic agents
were titrated using dilutions of 100 μM stock (A). Ricin and Abrin toxin were prepared from
natural source. Concentrations were determined by LRN immunoassay reactivity compared to
standards (B). HMEC-1 cells were treated with apoptogenic agents for 3 hours. Viability was
assessed using Trypan Blue exclusion.
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both produce a confluent monolayer (Figure 9A and 9B). Some cell rounding is apparent in the
infected culture, which we ascribe to an overgrowth of the cells. Little change in gross
morphology is observed for both uninfected (Cer) and infected (B + C) cells following two hours
of ceramide treatment (Figure 9C and 9D). Uninfected cells demonstrate a higher refractive
index, but overall the effect on the cell monolayer is minimal for both cultures. A higher
magnification does reveal some remarkable differences between infected and uninfected cells
after two hours of ceramide treatment, however. Uninfected ceramide-treated cells exhibit
cytoplasmic membrane blebbing (Figure 10A), a classic characteristic of early apoptosis events
(Green, 2003). B. henselae-infected cells treated with ceramide for the same amount of time
exhibit no cytoplasmic membrane blebbing (Figure 10B).
After four hours of treatment with ceramide, uninfected cells began to show pronounced
rounding of the cells and sloughing of cells from the monolayer, characteristics that become
more apparent at six hours of exposure (Figure 11A and 11C). During this same time period,
ceramide treatment has little visible effect on the appearance of the B. henselae-infected culture
(Figure 11B and 11D). By eight hours of treatment, the uninfected culture exhibits a pronounced
loss of monolayer integrity (Figure 12A), while the B. henselae-infected culture exhibits modest
rounding of the cells and sloughing of the monolayer (Figure 12B). Following 12 hours of
ceramide exposure the uninfected cells have lost nearly all adherent properties and nearly half of
the B. henselae-infected cells are rounding (Figure 12C and 12D). During this same time period,
ceramide treatment has little visible effect on the appearance of the B. henselae-infected culture
(Figure 11B and 11D).
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Cell Viability under Conditions Inducing Apoptosis.
The uptake of the vital dye Trypan Blue is associated with a loss of nuclear membrane
integrity, and is thus considered to be a reliable gross indicator of cell viability. Figure 13
illustrates the changes in cellular viability following ceramide treatment of both B. henselaeinfected (B+C) and uninfected (Cer) endothelial cells, as compared to controls that are not
exposed to ceramide. Ceramide exposure results in a steady decline in viability for both infected
and uninfected cells relative to the untreated controls; however, the decrease in viability is much
more pronounced in the uninfected culture, suggesting that B. henselae infection is providing a
protective effect against cell death.
Intracellular Expression of TRADD and FADD
Previous results (Figure 7) indicated that the levels of FADD in cells infected by B.
henselae are significantly reduced in comparison to their uninfected counterparts. To determine
the concentrations of TRADD and FADD in infected and uninfected cells under apoptotic
conditions, flow cytometric analysis was conducted on cells that had been visualized by
treatment with anti-TRADD and anti-FADD antibodies followed by incubation with a secondary
goat anti-mouse antibody. Following thirty minutes of ceramide treatment, TRADD producing
cells are minimal in both uninfected and infected cells (13% and 13.2% of the total cells,
respectively, Figure 14A and B). Following one hour ceramide treatment, TRADD-producing
cells remain low in the infected sample (14.9%, Figure 14C) but have begun to show an increase
in the uninfected cells (23.1% of total cells, Figure 14D). TRADD protein production spikes for
uninfected cells at 2 hours (75.94%, Figure 15A) and is still elevated at 3 hours (69.04%, Figure
15C) after ceramide treatment
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Figure 9. Cell Morphology—Controls and Two-hour Ceramide Treatment. Changes in cell
morphology with ceramide treatment. Uninfected of B. henselae-infected cells were exposed to
20 μM C2-ceramide for varying periods of time. A. Uninfected control cells prior to ceramide
exposure. B. B. henselae-infected control cells prior to ceramide exposure. C. Uninfected cells
after 2 hour exposure to ceramide. D. B. henselae-infected cells after 2 hour exposure. Figures
are representative of multiple independent experiments (n=3). After four hours of treatment with
ceramide, uninfected cells began to show pronounced rounding of the cells and sloughing of cells
from the monolayer, characteristics that become more apparent at six hours of exposure (Figure
11A and 11C).
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A

B

Figure 10. Classic Morphology of Early Apoptosis Event. Enlarged view of 2 hour 20 μM C2ceramide treatment. A. Uninfected cells after 2 hour exposure. Cytoplasmic blebbing is
highlighted in picture inset (red arrows) as compared to no blebbing (blue arrows). B. B.
henselae-infected cells after 2 hour exposure view after two hour ceramide exposure.
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Figure 11. Cell Morphology—Four- and Six-hour Ceramide Treatment. Change in cell
morphology with ceramide treatment. Uninfected of B. henselae-infected cells were exposed to
20 μM C2-ceramide for varying periods of time. A. Uninfected cells after 4 hour exposure to
ceramide. B. B. henselae-infected cells after 4 hour exposure. C. Uninfected cells after six hour
exposure to ceramide. D. B. henselae-infected cells after 6 hour exposure. Figures are
representative of multiple independent experiments (n=3).
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Figure 12. Cell Morphology—Eight- and Twelve-hour Ceramide Treatment. Change in cell
morphology following ceramide treatment. Uninfected of B. henselae-infected cells were
exposed to 20 μM C2-ceramide for varying periods of time. A. Uninfected cells after 8 hour
exposure to ceramide. B. B. henselae-infected cells after 8 hour exposure. C. Uninfected cells
after 12 hour exposure to ceramide. D. B. henselae-infected cells after 12 hour exposure. Figures
are representative of multiple independent experiments (n=3).

Among infected cells the proportion producing TRADD is only marginally enhanced at 2 hours
(28.70%; Figure 15B) and remains low at 3 hours (22.30%, Figure 15D). The proportion of
TRADD-positive cells in the uninfected sample has reached a plateau following 4 hours
ceramide treatment (69.81%, Figure 16A), while TRADD production in the infected cells is still
seen in only a small proportion of infected cells (16.13%, Figure 16B).
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Figure 13. Cell Viability by Trypan Blue Exclusion. Cell counts were determined in
triplicate. Uninfected cells treated with ceramide (Cer), Bartonella henselae-infected cells treated
with ceramide (B+C), and normal control cells (Ctrl) were assessed for cellular viability by
Trypan blue exclusion. Mock experimental controls for B+C and Cer were 69.16±4.67% and
65.04±1.41%. Graphs are representative of multiple independent experiments (n=3).

Thus, B. henselae infection is associated with a reduction in TRADD production under
conditions favoring apoptosis. Like TRADD, FADD is produced in more uninfected cells treated
with ceramide than in their B. henselae-infected counterparts. Even at thirty minutes of ceramide
treatment, the proportion of cells producing FADD in the uninfected cell population (60.7%;
Figure 17A) is significantly higher than that seen in the infected sample (40.2%; Figure 17B).
The numbers of FADD- producing cells in the uninfected sample increase further at one hour of
ceramide treatment (75.1%; Figure 17C), while FADD production is waning in the infected
sample (32%; Figure 17D) at the same time point. Over the next three hours, the proportion of
FADD-producing cells in the uninfected sample remains high (70% at 2 hours, Figure 18A; 64%
at 3 hours, Figure 18C), and 81% at 4 hours (Figure 19A) of ceramide treatment). During the
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same time period, the levels remain fairly static in the infected cell population, decreasing
slightly after 4 hours (30.3% at 2 hours (Figure 18B, 30.8% at 3 hours (Figure 18D), and 24.7%
at 4 hours, Figure 19B). Thus, as with TRADD, infection by B. henselae is correlated with lower
levels of FADD following the induction of apoptosis.
Inhibition of Caspase Activity in B. henselae Infected Cells
The effect of B. henselae infection on caspase activity was initially measured using the
Trupoint assay system (Perkin-Elmer). Controls using both normal control cells and untreated B.
henselae-infected cells were used for comparison. The results (Figure 20) reveal that the
enzymatic activity for caspase-8 and caspase-6 are enhanced in both B. henselae-infected and
ceramide-treated cells, as compared to their uninfected counterparts. Caspase-6 is significantly
increased in B+C cells, as compared to Cer cells, only following prolonged ceramide treatment.
Caspase-3 enzymatic activity, as seen in Figure 20A, is enhanced in Cer cells, as compared to
B+C cells or control cells. Enzymatic activity for caspase-3 rapidly increases following 1 to 4
hours of ceramide treatment.
Multicaspase Fluorescent Peptide Assay for Detection of Caspase Activity
The multicaspase fluorescent peptide assay makes use of a peptide substrate that can be
cleaved by caspases to yield fluorescent products. Although the assay does not differentiate
between a spectrum of caspases (caspase-2, -3, -6, -7, -8, and -10), it does provide a picture of the
overall levels of caspase activity, and hence the apoptotic condition of the cell (Slee et al., 1999).
Use of this assay indicates that B. henselae-infected cells demonstrate a rapid induction of
caspase activity following 2 and 3 hours of ceramide treatment (Figure 21A and 21C).
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Figure 14. TRADD Protein Expression Analysis by Flow Cytometry—Thirty minute and
One-hour Ceramide Treatment. TRADD protein expression for Cer and B+C cells following
30 minutes (A and B, respectively) and 1 hour (C and D, respectively) following ceramide
treatment. TRADD protein expression is baseline for both Cer cells (13.01%) and B+C cells
(13.19%) following 30 minutes ceramide treatment. Following 1 hour ceramide treatment,
TRADD protein expression increases for Cer cells (23.12%, C) as compared to B+C cells
(14.89%, D). Figures are representative of two independent experiments (n=2).
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A. 2 hour Cer

B. 2 hour B+C

C. 3 hour Cer

D. 3 hour B+C

Figure 15. TRADD Protein Expression Analysis by Flow Cytometry—Two- and Threehour Ceramide Treatment. TRADD protein expression for Cer and B+C cells following 2 (A
and B, respectively) and 3 hour (C and D, respectively) ceramide treatment. TRADD protein
expression is enhanced for Cer cells following 2 hour ceramide (75.94%, A) as compared to B+C
cells (26.70%, B). Following 3 hour ceramide treatment, TRADD protein expression decreases
for Cer cells (69.04%, C) and is relatively unchanged for B+C cells (22.30%, D). Figures are
representative of two independent experiments (n=2).
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A. 4 hour Cer
A

B. 4 hour B+C

Figure 16. TRADD Protein Expression Analysis by Flow Cytometry—Four-hour Ceramide
Treatment. TRADD protein expression is still enhanced for Cer cells following 4 hours
ceramide treatment (69.81%, A) as compared to slight decrease in B+C cells (16.13%, B).
Figures are representative of two independent experiments (n=2).

Multicaspase activation in these cells wanes following 4 hours of ceramide treatment, and
continues to decline following 6 hours of treatment (Figure 21E and G). Uninfected cells also
exhibit a rapid overall induction of caspase activity between 2 and 3 hours of ceramide treatment
(Figure 22A and 22C), but unlike their infected counterparts, they continue to demonstrate
induced caspase activity, as indicated by the maintenance of high fluorescence levels extending
after 4 and 6 hours of treatment (Figure 22E and 22G). Taken together, these results suggest that
B. henselae suppresses overall caspase induction under apoptotic conditions.
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A. 30 min Cer
A

B. 30 min B+C

C. 1 hour Cer

D. 1 hour B+C

Figure 17. FADD Protein Expression Analysis by Flow Cytometry—Thirty Minute and
One-hour Ceramide Treatment. FADD protein expression for B+C and Cer cells following 30
minutes (A and B, respectively) and 1 hour (C and D, respectively), following ceramide treatment.
FADD protein expression is enhanced for Cer cells following 30 minutes ceramide (60.65%, A)
as compared to B+C cells (40.19%, B). Following 1 hour ceramide treatment, FADD protein
expression increases for Cer cells (75.13, C) as compared to a decrease in FADD protein
expression for B+C cells (32.09%, D). Figures are representative of two independent experiments
(n=2).
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A. 2 hour Cer

B. 2 hour B+C

C. 3 hour Cer

D. 3 hour B+C

Figure 18. FADD Protein Expression Analysis by Flow Cytometry—Two- and Three-hour
Ceramide Treatment. FADD protein expression for B+C and Cer cells, following 2 hour (A
and B, respectively) and 3 hour (C and D, respectively) ceramide treatment. FADD protein
expression is enhanced for Cer cells following 2 hour ceramide (69.83%, A) as compared to B+C
cells (30.31%, B). Following 3 hour ceramide treatment, FADD protein expression decreases for
Cer cells (64.19%, C), while FADD protein expression remained unchanged for B+C cells
(30.76%, D). Figures are representative of two independent experiments (n=2).
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A. 4 hour Cer

B. 4 hour B+C

Figure 19. FADD Expression Protein Analysis by Flow Cytometry—Four-hour Ceramide
Treatment. FADD protein expression for both Cer and B+C cells, following 4 hour (A and B,
respectively) ceramide treatment. FADD protein expression is enhanced for Cer cells following 4
hour ceramide (81.70%, A) and decreases for B+C cells (24.70%, B). Figures are representative
of two independent experiments (n=2).

Effect of B. henselae infection on Ceramide-induced DNA Fragmentation
Flow cytometry was conducted in order to assess the effect of infection on DNA
fragmentation, which is an indicator of apoptotic conditions. The fluorescent intercalating dye
propidium iodide (PI) was used for cell staining. The DNA cell cycle was determined by FL-2
height (FL2-H) on a log scale: actively growing cells are expected to sort at positions
corresponding to G1 (1X DNA) through S and G2 (2X DNA), while cells in a resting state, G1/G0,
or those undergoing DNA fragmentation, sub G1/G0, should exhibit correspondingly less
fluorescence than their active counterparts (Elzbieta et al., 1998). Untreated B. henselae-infected
and uninfected cells demonstrate a typical DNA histogram distribution (Figure 27A and B
respectively), with cells distributed between G1, S and G2.
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Figure 20. Caspase Activity Assay. Caspase-3 enzymatic activity is suppressed for B+C cells as
compared to Cer treated cells (A). Both caspase-6 (A) and caspase-8 (C) enzymatic activity are
enhanced for B+C cells as compared to Cer cells. Enhanced enzymatic activity of caspase-6 and
caspase-8 for B+C cells is not over that of control (Ctrl) cells. However, caspase-6 and-8 activity
is similar to that of untreated B. henselae infected controls (B. alone). Significant enhanced
expression above controls is denoted by asterick (p<0.05). Values represent mean ±S.D of
multiple independent experiments (n=3).
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Figure 21. Multicaspase Fluorescent Substrate: B+C Cells. The cell permeable caspase
substrate is reactive to cleavage by caspase-2, 3, -8, -9, -10. Enhanced fluorescence indicates
increasing levels of overall caspase activity. Caspase fluorescence is baseline following 2 hours
(A), enhanced following 4 hours (E) and wanes following 6 hour ceramide treatment (G), for B.
henselae infected cells (B+C). Light micrographs demonstrate the presence and position of
endothelial cells.
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Figure 22. Multicaspase Fluorescent Substrate: Cer Cells. The cell permeable caspase
substrate is reactive to cleavage by caspase-3, -8, -9, -10. Caspase fluorescence is at baseline
following 2hours (A), but intensifying following 3 hours (C) and 4 hours (E) of ceramide
treatment. Fluorescence remains steady following 6 hours ceramide treatment (G) for uninfected
and ceramide treated cells (Cer). Light micrographs demonstrate the presence and position of
endothelial cells.
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Figure 23. DNA Cell Cycle Analysis. DNA content and cell cycle is determined by PI staining
of ethanol fixed cells. B.henselae alone control cells (A) has a small, but unsubstantial subG1/G0 population. Typical G1/G0, S, G2M histogram is observed in ceramide negative control
sample (B). Neither B+C nor Cer cells demonstrate significant sub-G1/G0 population for 1 hour
(C and D, respectively) and 3 hour (E and F, respectively) ceramide treatment. Six hour
ceramide-treated cells (H) demonstrate a remarkable sub-G1/G0 population as compared to 6 hr
B+C cells (G). Following 8 hour ceramide B+C cells demonstrate a minimal sub-G1/G0
population (I) as compared to a breakdown of standard DNA cell cycle profile (J). Likewise, at
no other timepoint is there a substantial sub-G1/G0 population. Histograms are representative of
multiple independent experiments (n=3).
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There is a small population of sub-G1/G0 cells in the infected sample, but the levels are
not substantial. Similar patterns are seen following one and 3 hours’ exposure to ceramide for
both infected (Figure 27C and 27E, respectively) and uninfected cells (Figure 27D and 27F,
respectively). Following six hours of ceramide treatment, the infected cells continue to be
distributed among the G1, S and G2 cycles (Figure 27G), but a large sub-G1/G0 population,
indicative of apoptosis, is clearly evident in the uninfected sample (Figure 27H). Only after 8
hours of ceramide treatment do any of the infected cells appear in the sub-G1/G0 stage, and their
numbers are minimal. In contrast, by this time, the uninfected cell population reveals a distinct
loss of the normal DNA cell cycle profile.

Discussion
Gram-negative Bacterial Infection and Apoptotic Response
Gram negative bacteria such as B. henselae are cloaked in lipopolysaccharide (LPS), and
the presence of Gram-negative bacterial LPS initiates the host anti-bacterial immune response
(Hu et al., 1998; Dauphinee and Karsan, 2006). The Gram-negative bacterial LPS are responsible
for the host pyrogenic response that occurs during bacterial sepsis (Hotchkiss et al., 2002;
Rudiger et al., 2008), and LPS alone is a known apoptosis agonist (Hull et al., 2002). Other
studies have shown that bacterial LPS induce apoptosis in HMEC-1 cells, provided there is an
additional agonist (Kyong-Bok et al., 1998). The presence of bacterial LPS causes microvascular
endothelial cells to excrete cellular TNF-α (Karsan et al., 1996). Excretion of TNF-α, in turn
promotes infiltration of immune system cells, particularly neutrophils (Bartee et al., 2008).
Likewise, TNF-α specifically upregulates NF-κB genes in HMEC-1 cells (Ades et al, 1992;
Candal et al, 1996). Microvascular endothelial cells, as mentioned earlier, are resistant to the
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cytolytic effect of TNF-α. However, TNF-α does induce a variety of other cell types to undergo
apoptosis via extrinsic apoptosis pathways (Haimovitz-Friedman, 1997). While microvascular
endothelial cells are resistant to the apoptogenic effect of TNF-α, the TNF-α-responsive genes
such as IL-8, VEGF, E-selectin and VCAM-1 are upregulated by its presence in the HMEC-1
endothelial cell line (Xu et al., 1994; Ades et al., 1992).
We assayed B. henselae-infected HMEC-1 cells for endotoxin concentration using a
standard limulus amoebacyte lysate (LAL) assay (FDA Guidelines, 1987). B. henselae endotoxin
(212±4 EU/mL) was not effective at inducing cell death alone following 12 hour incubation, a
time period that resulted in significant cell death in cultures containing an analogous quantity of
purified E. coli LPS (data not shown). Based on previous comparative studies correlating
bacterial colony forming units (c.f.u.) and endotoxin units (E.U.), this quantity of endotoxin
would correspond to approximately 1x106 cfu/mL (Huntington et al., 2007).
Other researchers have noted that apoptosis induced by bacterial LPS is potentiated by the
addition of exogenous TNF-α or a protein synthesis inhibitor (Hull et al., 2002). During natural
Gram-negative infection, the presence of bacterial Gram-negative LPS is an important factor for
inducing host cell sphingolipid conversion (Franchi et al., 2006). Sphingolipid conversion leads
to the generation of ceramide at the cell membrane. The use of ceramide as an apoptogenic agent
is discussed in detail later.
Bartonella henselae Infection and Death Receptors
Our early experiments revealed a rapid downregulation of Fas-associated death domain
(FADD) protein in HMEC-1 cells during the course of B. henselae infection (Figure 7). This
downregulation of FADD protein expression indicates that either Fas or TNF-receptor-1 (TNFR1) pathway is affected by the presence of B. henselae.
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Our initial observation of B. henselae-induced FADD protein downregulation was made
in the absence of any additional exogenous apoptosis inducer. It was this early revelation that led
to two important developments in our experimental design: 1) determination of B. henselae’s
ability to circumvent apoptogenic actions on the part of the cell following a direct challenge with
an apoptotic agent and 2) molecular characterization of pathways that utilize FADD as an
integral apoptotic modulator (TNF-R1 and Fas-receptor dependent pathways). We therefore
sought to determine if B. henselae were capable of “protecting” infected cells from apoptotic
challenge. To this end we examined a cadre of apoptogenic agents and conditions with divergent
modes of action (Table 2). Among these were exogenous TNF-α (Wesche-Soldato, et al. 2007;
Guoqing and Goeddel, 2002), C2-ceramide (Smith and Schuchman, 2008), Staurosporine (Zhang
et al., 2004), Camptothecin (Rath et al., 2008), etoposide/ET-18 (Torrecillas et al., 2006), Ricin
toxin (Korcheva et al., 2007; Rao et al., 2005), Abrin toxin (Qu and Qing, 2004) and Serum
starvation (Ajeno, et. al, 2004). Our examination of apoptosis inducing agents determined that
C2-ceramide was most desirable for our experimental model (Zhang et al., 2002) for the
following reasons: 1) camptothecin and etoposide yielded obliterated cell monolayers even at low
concentrations, 2) staurosporine had the inverse effect, causing endothelial cell death only at
higher concentrations but requiring a much longer time to exert its effect, and 3) ricin and abrin
toxin effectively killed endothelial cells with no morphological evidence of apoptosis.
True serum starvation is difficult to demonstrate with HMEC-1 cells and maintain
microvascular endothelial characteristics (Xu et al., 1994; Velma George personal
communication). The normal culture media contains 15% serum and historical information
demonstrates that HMEC-1 cells undergo substantial loss of viability with as little as 5% serum.
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C2-ceramide was the only apoptosis agonist we examined that provided a clear concentrationdependent cytotoxic effect (Figure 2; Table 1), so it was the agent of choice for our experiments.
C2-ceramide is a short-chained, cell permeable exogenous apoptosis inducer that is
optimal for use with microvascular endothelial cell cultures (Fillet et al., 2003). First, exogenous
ceramide treatment mimics the normal cellular responses to the presence of Gram-negative LPS
exposure (Barber et al., 1996). Second, ceramide conversion plays an integral role in extrinsic
pathway signaling. Lastly, of the apoptogenic agents tested, C2-ceramide demonstrates a linear
dose and time dependence (Samadi, 2007; Figure 8).
Sphingolipids and Their Role in Death Receptor Apoptosis Induction
Metabolism of cell membrane sphingolipids generates endogenous ceramide in response
to early apoptosis signaling events (Kolesnick, 2002; Ogretum and Hannun, 2004). A cellular
function of ceramide is to modulate protein kinase pathways, leading to activation of downstream
cellular apoptosis modulators (Basu et al., 1998). Another function of ceramide is in aiding in the
formation of lipid rafts (Gulbins et al., 2004; Browne and London, 1998). Lipid raft formation
facilitates the clustering of cell surface transmembrane receptors, including death receptors
(Gulbins, 2003). Clustered death receptors, specifically TNF-receptor-1 or Fas, are the initial
signal for extrinsic apoptosis pathways (Gulbins and Li, 2006).
Effect of B. henselae on Ceramide-induced Changes in Cellular Morphology
Ceramide has a progressive effect on microvascular endothelial cell integrity, as
demonstrated by gross cellular morphology for both ceramide-treated uninfected cells (Cer) and
ceramide-treated B. henselae-infected cells (B+C). Both control uninfected (Figure 9A) and
control B. henselae-infected cells consist of confluent cell monolayers (Figure 9B). Control cell
morphology represents the end of the experimental timeline. The presence of some rounded cells
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in the B. henselae alone control may be attributed to overconfluence of the endothelial cell
monolayer. The obvious toxic effect of ceramide is more pronounced for Cer cells following
longer ceramide treatment duration (Figure 9C, Figures 11A and C, Figures 12A and C). The
appearance of Cer cells stands in stark contrast to their B. henselae-infected counterparts (B+C)
withstanding the same ceramide challenge (Figure 9D, Figures 11B and D, Figures 12B and D).
The progression of cellular damage emphasizes that ceramide is time-dependent in its cytotoxic
morphological manifestation for microvascular endothelial cells.
Previous research suggests that the presence of B. henselae allows the host cells to
circumvent apoptosis progression (Kirby and Nekorchuk, 2002.; Minnick et al., 2003). It is
important to note that the efficiency of B. henselae infection of cultured cells is approximately
40% (Dr. Russell Regnery, personal communication). Our experience using Gimenez staining of
B. henselae-infected HMEC-1 cells is in agreement with that estimate. In our model, the
proximity of B. henselae to uninfected cells within the infected cellular monolayer did not
alleviate cell death. Therefore, we postulate that some loss of viability for B+C cells is due to
uninfected cells within the B+C culture monolayer succumbing to the apoptogenic effect of
ceramide. We observed no overriding “bystander” protective effect for uninfected cells from
proximal B. henselae-infected cells.
Trypan Blue was used to determine the cellular viability for both B. henselae-infected
(B+C) and uninfected ceramide-treated cells (Cer) and control cells (Bird and Forrester, 1981).
Trypan Blue determines viability due to exclusion of dye by the intact cellular outer membrane
(Huggett and Suffolk, 1936). Assays that measure substrates of cellular respiration, such as those
that use the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), are desirable in some experimental models because their effects can be quantified. The
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addition of bacteria (Gebran et al., 1994) and high serum concentrations in the cellular assay
pose obstacles regarding the reliability of MTT assay results, however (MTT Assay Technical
Data Sheet, Promega, Madison, WI). As mentioned previously, HMEC-1 cells do not maintain
their desired cell characteristics when subjected to low serum concentrations (Ades et al., 1992).
In addition, the presence of bacterial NAD dehydrogenase in the endothelial cell model creates
aberrant results using MTT. For these reasons, we employed the use of Trypan Blue as a more
reliable means of assessing viability considering the experimental parameters we used. In short,
while both B+C and Cer cells experienced loss of viability, B. henselae-infected cells were
markedly more viable and the endothelial cells were resistant to the cytotoxic effect of ceramide.
Viability of ceramide treated uninfected cells rapidly declines in the time interval between 30
minutes and 6 hours of treatment (Figure 13). While the presence of B. henselae in infected
culture cells enhances overall cellular viability, there appears to be a level of cellular stress for
the B+C cell culture as demonstrated by gross morphology when compared to uninfected- and
untreated control cells. It is possible that the presence of B. henselae creates a competition for
carbon sources in the cell culture media or more likely a mild shift in the media pH. Other
researchers have demonstrated that prolonged exposure of endothelial cells to B. henselae
promotes dramatic cell proliferation (Maeno et al., 1999; Dehio, 2003). Our research
demonstrates that while B. henselae protects microvascular endothelial cells from apoptosis, it
has little effect on cell proliferation within the experimental timeframe used here (data not
shown). We assert that B. henselae’s intracellular survival tactic does not rely on enhancing cell
proliferation and overall viability alone. Full characterization of the endothelial cell genes
modulated during B. henselae intracellular infection would help to address this issue.
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TRADD and FADD Intracellular Protein Expression
Contrary to the induction of gene expression, described in Chapter 3, changes in the
intracellular protein concentration of TRADD and FADD can be caused by multiple factors. The
percentage of TRADD/FADD positive cells indicates that these proteins are available from
cytoplasmic pools, and could arise either from new transcription or translation, or from
translocation from organelle storage. Untreated and uninfected cells have a consistent baseline of
TRADD intracellular expression for both B+C and Cer cells (~13% positive cells). Following
prolonged ceramide treatment, the percentage of TRADD positive cells increases for both B+C
and Cer cells. Following the initiation of elevated TRADD expression, Cer cells maintain a high
level of TRADD thereafter. Intracellular TRADD protein concentrations are likewise elevated for
B+C cells, although the percentage of positive cells is nearly three-fold lower at its peak.
An analysis of FADD concentrations reveals a pattern that is striking different from that
of TRADD. The percentage of FADD positive Cer cells is elevated for all time-points. However,
a comparison of B+C and Cer cells reveals two unique differences. First, the presence of B.
henselae appreciably diminishes FADD levels at all time points. Second, the presence of B.
henselae causes a suppression of FADD expression following prolonged ceramide treatment. In
fact, the presence of B. henselae causes nearly a four-fold decrease in the percentage of FADD
positive cells following 4 hours of ceramide treatment.
Unlike TRADD, the cellular pool of FADD is not known (Screaton et al., 2003). FADD
does possess a nuclear localization sequence. However, it has been demonstrated that in a single
population FADD can be localized in either the cytoplasm or the nucleus (Gomez-Angelats and
Cidlowski, 2003). TRADD is primarily stored in the endoplasmic reticulum. However, both
nuclear import and export sequences for TRADD have been identified (Morgan et al., 2002;
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Farrando-May, 2005). The permeabilization technique used in our studies is not sufficient to
efficiently solubilize nuclear or endoplasmic reticulum membranes. Therefore, we conclude that
the increase in TRADD levels is due to either new transcription, or translocation from the ER.
Caspase Activity
Caspase activity was assessed by the ability of available caspase to proteolytically cleave
target peptides. The designer target peptides, which utilize a Europium-labeled reporter and a
QSY-7 quencher, are “specific” for a particular caspase. The target peptide includes a target
sequence that the enzymatically active caspase will cleave. The close proximity of the reporter
and quencher in the intact target peptide results in total quenching of emitted signal following
exposure to excitation. Proteolytic cleavage of the target peptide results in emission of a
“fluorescent” signal following excitation. The LANCE system uses a caged chelated lanthanide
(Europium) as the reporter molecule.
The caspase-3 assay demonstrated that proteolytic activity was enhanced at all time points
in Cer cells as compared to B+C cells. Additionally, caspase-3 activity was significantly
enhanced for time points 1 to 4 hours over untreated control cells and untreated B. henselae
infected cells. Caspase-3 enzymatic activity waned by 8 hours post ceramide treatment. As
described previously, viability for both Cer and B+C cells is adversely affected by 8 hours
ceramide treatment. This may account for the decline in caspase-3 activity. Additionally, all of
the cellular substrates targeted by caspase-3 may be cleaved at this point, leading to a suppressive
effect of caspase-3.
In contrast to the results observed with caspase-3, caspase-6 proteolytic activity was
enhanced in ceramide treated B. henselae-infected cells as compared to their uninfected
counterparts. This result is in direct conflict with previous reports of B. henselae’s ability to
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disrupt apoptosis (Kirby et al., 2001). Still, at no time point was the proteolytic activity
significantly greater than that of untreated uninfected control cells, or untreated B. henselaeinfected control cells. The work of Kirby and Nekorchuk demonstrated that the presence of B.
henselae suppressed caspase-3, caspase-8 and pan-caspase activity for control cells and serumstarvation induced cell death. Their research utilized umbilical vein endothelial cells which have
different responses to apoptosis stimuli than microvascular endothelial cells. In addition, our
results demonstrate that the mere presence of B. henselae does not suppress enzymatic activity of
caspase-3 and caspase-8. In fact for both caspase-3 and -8, B. henselae infected untreated cells
have equal to or higher caspase activity for the respective caspase. The difference could simply
be the use of two different cell models. The dynamics of apoptotic response tends to be tissue
and cell specific.
Like caspase-6, caspase-8 exhibited significantly enhanced activity in ceramide treated B.
henselae-infected cells (B+C) relative to their uninfected counterparts, especially at the 3 and 4
hour time-points. Moreover, untreated and uninfected control cells and untreated B. henselaeinfected control cells exhibited greater caspase-8 activity than either B+C or Cer cells. As
mentioned previously, enzymatic activity of caspase proteins has been used as the empirical
measure of caspase involvement. Caspase activation and caspase activity are not always
synonymous (Kottke et al., 2001). We know that several caspase proteins do not need to be
proteolytically active in order to carry out their function (Zimmerman and Green, 2001).
The enzymatic activity counts of caspase-3 were at least three times those of either
caspase-6 or -8. This is probably because caspase-3 is both the most abundant caspase and the
initiator of both intrinsic and extrinsic apoptotic pathways.
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Suppression of Overall Caspase Induction by B. henselae
The MulticaspaseTM fluorescent assay is a broad spectrum caspase substrate that targets
caspases-1, -3, -6, -7, -8 and -9. Again, this assay uses cleavage of fluorescent pan caspase target
peptide to assess overall caspase activity. As a pan-caspase assay, it does not differentiate
between the activites of individual caspases. B. henselae-infected cells treated with ceramide
(B+C) exhibited a rapid, but truncated induction of overall caspases activity. The multicaspase
assay revealed less overall caspase enzymatic activity in B + C cells than for cells treated with
ceramide alone. More importantly, enhanced overall caspase activity for Cer cells lasted for a
longer time (up to 6 hours). From these results, we conclude that the presence of B. henselae
inhibits overall caspase induction caused by the induction of apoptosis.
The work performed by Kirby and Nekorchuk did utilize a pan-caspase assay. In their
research the presence of B. henselae suppressed pan-caspase activity. However their research
employed a “pan-caspase” assay that is preferential for caspase-3 and -7 utilizing umbilical vein
endothelial cells in the presence and absence of serum. Our data suggests that the presence of B.
henselae suppresses pan-caspase activity (caspase-1, -3, -4, -5, -6, -7, -8 and -9) following
ceramide-induced apoptsis using microvascular endothelial cell line.
B. henselae Suppresses Ceramide-induced DNA Fragmentation
Flow cytometric assessment of the DNA cell cycle utilizes propidium iodide (PI) as a
DNA fluorescent intercalating dye to determine DNA content. Following cellular membrane
permeabilization, PI intercalates into the DNA of any double-stranded DNA it encounters.
Intercalated PI is stoichiometrically proportional to DNA content. The height of the fluorescent
pulse is proportional to the intensity of the fluorescent signal, while the width of the signal is
proportional to the time required for the permeabilized fluorescent cell to travel across the beam
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of the laser. The area is calculated from the fluorescence integral to the cell that traveled across
the laser. Fluorescence area is important if we were interested in discriminating DNA content of
a cell doublet from the DNA content of a G2/M cell (Nunez, 2001).
Considering the size of endothelial cells, the fluorescent height of a G0 singlet is the same
as that of a G0 doublet because only one nucleus will occupy the laser space at a time. However,
the width of a G0 doublet will be twice that of a G0 singlet because it will take twice as long to
traverse the laser beam. Likewise, the fluorescent area of a G0 doublet will be twice that of a G0
singlet (Zibigniew Darzynkiewicz, personal communication). The data were acquired by gating
on the population that correspond to G0/G1/S/G2M singlet cells, excluding doublets, triplets and
so on. Normal cell cycle distribution includes a large G1/G0 peak followed by a plateau of Sphase cells and concludes with a G2/M peak of nearly ½ the height of the G1/G0 peak. Any peaks
to the left of or smaller than the G1/G0 peak are considered to be sub-G1/G0 peaks and therefore
apoptotic.
We chose to display DNA content using FL-2 height because it allows us to display in a
log scale, making all low molecular weight DNA visible. Most low molecular weight DNA is
precluded from view when assessed in a linear FL-2 area histogram. However, a large sub-G1/G0
population is observed at six hours of ceramide treatment for the Cer cells (Figure 23H). Eight
hours of ceramide treatment produces a complete loss of DNA cell cycle integrity for Cer cells,
as determined by a flattening of peak height (Figure 28J). In contrast, the B + C cells show no
significant apoptotic population up through six hours of ceramide treatment (Figure 23G). Only
after eight hours of ceramide treatment does a small apoptotic peak begin to emerge.
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CHAPTER 3
BARTONELLA INHIBITS GENE EXPRESSION OF APOPTOSIS MODULATORS

Introduction
Intracellular pathogens are known to influence gene expression in their host cells (Darby
et al., 2007). Genes whose expression is increased by these pathogens include proliferation
associated genes, anti-apoptosis associated genes and in some cases apoptosis genes (Gao and
Kwaik, 2000). It is well known that bacteria, in particular Bartonella species, influence the
expression of NF-κB associated gene products (Dehio, 2001). B. henselae exploits all of the
extrinsic genes within the TNF-R1 pathway. This is intriguing due to the fact that endothelial
cells, the usual host for this bacterium, are not responsive to the apoptosis effects of TNF-α
(Viemann et al., 2006).
To ensure chronic intracellular infection, B. henselae must inhibit apoptosis. As
previously described, B. henselae suppresses the protein expression and activity of several TNFR1 dependent pathway modulators. The experiments described here were designed to determine
the effect of B. henselae infection on gene expression following direct apoptotic challenge. Two
commonly used methods designed to investigate changes in gene expression are microarray
analysis and approaches involving real-time RT-PCR. The use of ceramide, our selected
apoptogenic agent, precluded the use of expression microarray chips due to the fact that the
cytotoxity of ceramide dramatically reduced the number of intact cells and thereby the total
mRNA concentration (Nagata et al., 2003). Therefore, we chose to investigate the effect of B.
henselae on gene expression using multiplex real-time PCR.
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Real-time RT-PCR assays measure the amount of transcript that is present in a given
sample under a defined set of conditions. Following reverse transcription of the targeted RNA,
.the amount of gene product is monitored after each amplification cycle and the number of cycles
required for the product concentration to reach a pre-defined threshold (CT) is determined. The
higher the CT value (i.e., the longer it takes to reach the designated threshold concentration), the
lower the initial concentration of the RNA in the original sample Thus, the CT value provides an
estimate of the “quantity” for the specific gene target. By comparing the CT value for a gene-ofinterest (GOI) to the CT value of a benchmark or normalizing gene such as glyceraldehyde-6phosphate dehydrogenase (GAPDH), the relative abundance of that GOI can be determined.
Approximately 3.3 cycles change in the CT value is equal to one log, or a 10-fold difference in
gene expression. Multiplexing the real-time RT-PCR assay provides an added advantage, since it
allows for simultaneous comparisons within a single reaction vessel.

Materials and Methods
RNA Extraction
Suspended and floating cells were pelleted from the media of 6-well culture dishes and
spun for 3 minutes at 1,000 xg. Cell monolayers and pelleted cells were pooled together. Cells
were lysed with 100 μL of Roche MagNApure RNA II Lysis Buffer (Roche, Indianapolis, IN.).
RNA II Lysis Buffer, at a volume of 100 μL, was added to the sample processing tray for each
sample. The total volume of lysed cells in the RNA II Lysis Buffer was added to the sample
processing tray according to the manufacturers’ protocol. RNA extraction was performed using
the robotic MagNApure system using the RNA II kit following the High Performance RNA II
protocol according to manufacturers’ instructions.
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RNA was pelleted by adding 100 μL 95% ethanol, then decanting off the ethanol.
Contaminating DNA was removed by adding 5 μL RNase-Free DNase I and bringing the total
volume up to 200 μL with 1X DNase Buffer (Epicentre, Madison, WI). The dissolved RNA was
incubated for 30 minutes at 37 oC. A volume of 200 μL of 2x T and C Lysis Solution was added
followed by vortexing for 5 seconds. A volume of 200 μL of MPC Protein was added and the
solution was vortexed for 10 seconds and placed on ice for 5 minutes. Debris was pelleted by
centrifugation at 10,000 xg in a microcentrifuge. The supernatant was transferred to an RNasefree microfuge tube, after which 500 μL of isopropanol was added and the tube inverted several
times.
The purified RNA was pelleted by centrifugation at 4 oC for 10 minutes. The RNA pellet
was washed 2x with 75% ethanol, in nuclease-free water, and centrifuged at 10,000 xg for 5
minutes. RNA pellet was dissolved in 200 μL TE buffer supplemented with tRNA added to a
final concentration of 1 μg/100 μL (Ambion, Austin, TX). tRNA was also added to nuclease-free
water (Promega, Madison, WI) at 10 μg/mL, for all RNA dilutions.
Real-time RT-PCR Primers
Primer sequences were as follows.
Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward 5’-TGGGCTACACTGAGCACCAG-3’
Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) reverse 5’-CAGCGTCAAAGGTGGAGGAG-3’
Caspase-8 (Cas8) forward 5’-GCCTGGACTACATTCCGCA-3’
Caspase-8 (Cas8) reverse 5’-CCTGGAGTCTCTGGAATAACATCA-3’
Caspase-3 (Cas3) forward 5’-TGTTCCATGAAGGCAGAGCC-3’
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Caspase-3 (Cas3) reverse 5’-TGCGTATGGAGAAATGGGC-3’
FADD forward 5’-CTTCGGATGAGGCCCTCAT-3’
FADD reverse 5’-TCTAGGGCACTGCAGGGCT-3’
TRADD forward 5’-GATGGCAGCTGGGCAAAAT-3’
TRADD reverse 5’-GCGAGGACTCCACAAACAGG-3’.
Probes
Target probe sequences and chemistries are as follows.
GAPDH probe 5’FAM-TGGTCTCCTCTGACTTCAACAGCGACAC-3’BHQ;
Cas8 probe 5’YamY-AGGAAGCAAGAACCCATCAAGGATGCC-3’BHQ;
Cas3 probe 5’Cy5-TGGACCACGCAGGAAGGGCC-3’BHQ;
FADD probe 5’-YakY-CCCATTCGGGAGATCATGTCTCACTTCA-BHQ-3’
TRADD probe 5’-Cy5-CACGAAGAGTGGGTGGGCAGCG-BHQ-3’;
Multiplex RT-PCR Conditions
Multiplex RT-PCR Master Mix contained the following components per reaction: 11.5
μL QuantitectTM Probe RT-Master Mix, 0.25 μL QuantitectTM RT Mix (Qiagen, Valencia, CA);
2.5 μL LC-FastStart Enzyme w/o MgCl2 (Roche, Indianapolis, IN) and 0.125 μL nuclease-free
water (Promega, Madison, WI). The multiplex RT-PCR Master Mix components were
supplemented with an additional 0.5 mM MgCl2 (Roche, Indianapolis, IN), 0.8 mM dNTPs
(Promega, Madison, WI) and 5 U per reaction Platinum TaqTM (Invitrogen, Carlsbad, CA).
The Qiagen RT Mix contains a proprietary mixture of OmniscriptTM and SensiscriptTM
reverse transcriptases, and HotstartTM Taq DNA polymerase and 4mM MgCl2. Further, the
QuantitectTM Probe RT-PCR Master Mix contains a proprietary mixture of dNTPs and buffers.
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Primers/probes were used at the following concentrations: GAPDH primers/probe at
250nM/50nM; and FADD and TRADD primers/probe at 500nM/100nM and 1000 nM/200nM
respectively. GAPDH, Cas8 and Cas3 primers/probe were used at 250nM/50nM, 500/100 nM
and 1000nM/200nM, respectively. Cycling conditions were 48 oC for 30 minutes, 95 oC for 15
minutes followed by 45 cycles of 95 oC for 10 seconds and 60 oC for 90 seconds. Data were
acquired (i.e., optics were on) during the 60 oC step.

Results
Real-time RT-PCR was used to determine the effect of B. henselae infection on the
expression of selected apoptosis-associated genes. As an initial step, parameters optimizing the
conditions for reproducible amplification were established. Development of real-time PCR assay
conditions involves the selection of an optimal primer/probe set, the titration of primer/probe
combinations to determine optimal concentration, the titration of the optimal MgCl2
concentration, and determination of the need for supplemental components to ensure RNA
template integrity. Several genetic targets were evaluated for assessing apoptosis induction
(Table 2).
The panel of primer/probe sets described in Table 2 was designed using Primer
ExpressTM software. Complete mRNA sequences of the desired human apoptotic genes were
analyzed by BLAST gene sequences available through GenBank. Targets that had multiple
primer/probe options were further screened to determine the optimal primer/probe set (Figure
24). Different primer/probe sets directed against the same gene target can display variability in
the efficiency of amplification and signal intensity for that gene target. For this reason each
possible gene target primer/probe set is screened for amplification efficiency. For the sake of
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simplicity, screening of primer probe sets is paired with MgCl2 titration (Figure 24). The addition
of supplemental yeast tRNA was determined at the onset to be necessary to ensure RNA stability
and reproducible curves (Figure 25). tRNA was added to all RNA stocks and template diluent to
both stabilize the target and ensure proper template recovery from frozen template.
Optimal primer/probe concentrations were determined by serial two-fold titration of
primer/probes from 1μM/200nM to 250nM/50nM (Figure 26). The primer/probe set for a desired
gene target that demonstrated: 1) a strong reproducible fluorescent signal, and 2) the absence of a
no-template-controls (NTC) signal, was selected for further study (See Materials and Methods
primer and probe sequences). Previous experience demonstrated that additional dNTP’s and
supplemental Platinum TaqTM were necessary for multiplexing a real-time PCR assay (data not
shown).
Standard curves of RNA template verify both the efficacy and robustness for real-time
RT-PCR assays under the conditions optimized above. A linear dilution series demonstrates that
each real-time RT-PCR assay is reliable across a wide concentration range. The linearity of the
CT curve provides verification that amplification efficiency is maintained across a linear dilution
series of input template for TRADD (Figure 27), FADD (Figure 28), Caspase-8 (Figure 29) and
Caspase-3 (Figure 30). In addition to standard curves for each gene target using control cells,
RNA templates were isolated from infected and uninfected cell samples after 1, 2, 3, 6 and 12
hours of ceramide treatment. The efficiencies of gene amplification ranged between 90% and
100% for all gene targets, all sample types and all time points (data not shown).
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Table 2. Gene Targets Tested.
Target

Number of primer/probe sets

Fluorophore

tested
18S rRNA

1

FAM

RNAse P

1

FAM

β-actin

1

FAM

GAPDH

2

FAM

TRADD

3

Cy5

FADD

2

Yak Yellow

Fas

2

Yak Yellow

Caspase-8

3

Yak Yellow

Caspase-3

2

Cy5

MDR-1

1

Yak Yellow

TGF-β

1

Yak Yellow

Several targets were selected for assessing apoptosis induction. The number of primer/probe sets
was determined by Primer Express software blast of target gene sequences. Targets that had
multiple primer/probe sequences were further screened to determine the optimal primer/probe
set. Fluorophore listed is the dye used for the optimal primer/probe set.
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Figure 24. Supplemental Magnesium Titration and Multiple RT-PCR Primer/Probe Sets.
Each gene target primer probe set was optimized for supplemental magnesium in PCR Master
Mix. The cluster of markers cross the threshold between cycle 26-28. Prospective primer probe
sets were identified by Primer ExpressTM software (Roche, Indianapolis, IN.)

Figure 25. Reproducibility of Multiplex RT-PCR Requires tRNA. Real-time RT-PCR does
not yield reproducible CT values in the absence of stabilizing tRNA. Replicates of a single RNA
template aliquot demonstrate a wide range of cycle-threshold (CT ) values
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Figure 26. Primer and Probe Titration. A linear dilution of primer/probe were used to
determine optimal primer/probe concentration. Optimal primer/probe concentrations were
determined for each gene target (FADD primer/probe used as example).

Most test samples were >95% efficient for amplification. RNA templates from infected cells
exhibited little variability in CT values across all time points, as compared to a slightly broader
variability in CT values for cells treated with ceramide alone across all time points (data not
shown).
Use of Multiplex Real-Time RT-PCR to Measure Relative Apoptotic Gene Expression for
Early and Late Apoptotic Genes
Multiplex real-time RT-PCR provides a graphic and simultaneous representation of the gene
expression for the gene-of-interest (GOI) and the reference house-keeping gene.
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y= -3.6682 + 30.604

Slope = -3.3219
R2 = 0.9953
E = 2.0000

y = -3.582 + 22.509
Slope= -3.5874
R2 =0.9947
E = 1.9000

Figure 27. Standard Curve of TRADD Gene Expression. A comparison of standard curves for
TRADD gene expression. RNA templates from control cells were diluted in a serial fashion. The
curves demonstrate linear gene expression of TRADD as a function of serial dilution of gene
template. Successive 2-fold dilutions of template yield corresponding increases in CT values.
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y = -3.6159 + 29.46
Slope = -3.3219
R2 =0.9953
E = 2.0000

y = -3.582 + 22.509
Slope = -3.5874
R2 =0.9953
E = 1.900

Figure 28. Standard Curve of FADD Gene Expression. A comparison of standard curves for
FADD gene expression. RNA templates from control cells were diluted in a serial fashion. The
curves demonstrate linear gene expression of FADD as a function of serial dilution of gene
template. Successive 2-fold dilutions of template yield corresponding increases in CT values.
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y = -3.9161 + 31.217
Slope = -3.3219
R2 =0.9953
E = 2.000

y = -3.582 + 22.509
Slope = -3.5874
R2 =0.9953
E = 1.900
Figure 29. Standard Curve of Caspase-8 Gene Expression. A comparison of standard curves
for Caspase-8 gene expression. RNA templates from control cells were diluted in a serial fashion.
The curves demonstrate linear gene expression of Caspase-8 as a function of serial dilution of
gene template. Successive 2-fold dilutions of template yield corresponding increases in CT
values.
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y = -3.6791x + 28.04
Slope = -3.3219
R2 =0.9953
E = 2.000

y = -3.582 + 22.509
Slope = -3.5874
R2 =0.9953
E = 1.900

Figure 30. Standard Curve of Caspase-3 Gene Expression. A comparison of standard curves
for Caspase-3 gene expression. RNA templates from control cells were diluted in a serial fashion.
The curves demonstrate linear gene expression of Caspase-3 as a function of serial dilution of
gene template. Successive 2-fold dilutions of template yield corresponding increases in CT
values.

71
In the analysis conducted here, the gene-of-interest (TRADD, FADD, Caspase-8, or Caspase-3)
is normalized to the reference housekeeping gene (GADPH) for each sample by subtracting the
average CT value of the reference gene (GAPDH) from the average CT value for the GOI, called
∆CT. The normalized GOI from the sample of interest or focus sample, is then subtracted from
the normalized GOI of the standardizing sample (Winer et al., 1999; Livak and Schmittgen,
2001). The normalized gene expression of the reference sample is subtracted from the
normalized gene expression of the test sample which is called the ΔΔCT. Specifically, relative
gene expression (R.E.) is mathematically determined as follows:
R.E.= 2^(Normalized Gene Expression Test Sample)-(Normalized Gene Expression Reference Sample)
R.E=2^(GOI Test-NG Test)-( GOI Reference-NG Reference)
Ref. Sample= cell template used as “benchmark” reference or calibrator sample
Test Sample= sample where the gene expression level is desired.
GOI=gene of interest (target gene)
NG=Normalizing gene (GAPDH) or glyceraldehyde-6-phosphate dehydrogenase.
It is worth noting that by adjusting which sample is the test and which is the reference or
calibrator one can determine the gene expression fold-increase as it relates to the reference
sample.
Apoptosis was induced by ceramide treatment of uninfected and B. henselae-infected
cells, and its effect on gene expression was monitored in a time-dependent manner. Gene
expression was determined for the gene targets TRADD, FADD, caspase-8 and caspase-3 and the
normalizing house-keeping gene, GAPDH, as described. Enhanced gene expression was defined
as the net difference in transcript production for the uninfected cells and infected cell (Figures 27,
28, 29 and 30).
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TRADD Gene Expression
Real-time RT-PCR revealed a time-dependent trend in enhanced TRADD gene
expression for ceramide-treated cells. After a single hour of treatment, there was virtually no
separation in TRADD CT curves for RNA isolated from neither infected or uninfected cells, nor
was there detectable separation of the GAPDH CT curves (Figure 31A). After 2 hours, however,
there was a significant increase in the separation in the GAPDH curves (Figure 31B, ~4.15
cycles) for Cer cells as compared to B+C cells with an average fold increase of 13.14 (Figure 32)
and a ΔΔCT of -3.72 (Table 3). Likewise at the same time-point the fold increase was 9.76 and
0.51 for Cer cells vs Controls and B+C cells vs. Controls, respectively (Figure 32; Table 2B and
2C). By 3 hour of ceramide treatment the fold-increase in TRADD gene expression was 3.91,
2.00 and 0.74 for Cer vs B+C, Cer vs Control and B+C vs Control, respectively (Figure 32; Table
3).
FADD Gene Expression
Real-time RT-PCR analysis reveals an enhancement of FADD expression similar to
that which was observed with the TRADD gene. Following one hour of ceramide treatment, no
separation of FADD CT curves for templates derived from either infected or uninfected cells
was detected (Figure 33A), but after two hours, there was a significantly higher level of the
FADD transcript (relative to the GADPH standard) in the ceramide treated uninfected cells.
The difference became even more pronounced after three hours (Figure 33B), with a 4.84 and
2.43 fold increase for Cer vs B+C and Cer vs Control, respectively (Figure 34; Table 4A and
4C). FADD gene expression returned to baseline by the 6-hour time point.
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A

TRADD

B

Figure 31. Multiplex Real-time RT-PCR for TRADD Gene Expression. TRADD gene
expression (upper panel) is normalized to GAPDH gene expression (lower panel). Gene
expression of TRADD is shown at 1 hour (Figure 31A) and 2 hour (Figure 31B). Ceramide
treatment for 1 hour had no significant variation in gene expression between sample types. Two
hour ceramide treatment demonstrates enhanced gene expression for TRADD (Figure 31B).
Figure 31 is representative of multiple independent experiments (n=3). Experimental samples
were run in triplicate
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TRADD Gene Expression
14.00
12.00

B+C vs Ctrl

8.00

Cer vs Ctrl
6.00

Cer vs B+C

Fold-increase

10.00

4.00
2.00
0.00
1 hr

1.5 hr

2 hr

3 hr

6 hr

12 hr

time

Figure 32. TRADD Gene Expression. Gene expression is represented as relative fold-increase
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer)
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the
ΔΔCT method. Values represent mean of fold-increase.

Caspase-8 and Caspase-3 Gene Expression
As with TRADD and FADD gene expression, the level of expression of the genes coding
for Caspase-8 and Caspase-3 in B. henselae-infected cells following ceramide treatment was
found to be significantly less than that of the uninfected control cells. The differences in gene
expression became apparent at two hours post-ceramide treatment, reaching a peak at two hours
for caspase-8 (4.45 fold-increase, Figure 36; Table 5) and caspase-3 (3.68 fold-increase, Figure
38; Table 6), then decreasing over the course of the next several hours (Figure 36 and 38; Table 5
and 6).
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Table 3. TRADD Gene Expression Summary.
Cer vs
B+C
A

B+C vs
Ctrl
B

Cer vs
Ctrl
C

TRADD
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT

1 hr
1.56
0.43
26.27

1.5 hr
5.34
0.59
28.11

2 hr
13.14
0.69
28.04

3 hr
3.91
2.39
28.95

6 hr
0.74
0.02
29.75

12 hr
1.09
0.03
28.22

16.95

21.26

22.19

20.65

19.05

18.28

9.32
26.43

27.89
26.93

5.86
27.56

8.30
27.50

10.50
27.96

9.94
27.20

16.86

17.72

17.99

17.38

17.68

17.13

9.94

9.27

9.57

10.12

10.28

10.07

ΔΔCT

-0.61

-2.41

-3.72

-1.82

0.43

-0.13

TRADD
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT
ΔΔCT

1 hr
0.52
0.15
27.20

1.5 hr
0.45
0.08
27.96

2hr
0.51
0.01
27.50

3 hr
0.74
0.08
27.56

6 hr
0.92
0.12
26.93

12 hr
0.75
0.22
26.80

17.13

17.68

17.38

17.99

17.67

16.86

10.07
26.66

10.28
26.66

10.12
26.77

9.57
26.77

9.27
26.77

9.94
26.05

17.56

17.56

17.63

17.63

17.63

16.56

9.10

9.10

9.14

9.14

9.14

9.49

0.96

1.18

0.98

0.43

0.13

0.45

TRADD
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)

1 hr

1.5 hr

2 hr

3 hr

6 hr

12 hr

1.12
0.03
26.27

4.89
0.09
28.11

9.76
0.57
28.04

2.00
1.26
28.95

0.33
0.07
29.75

0.58
0.18
28.22

16.95

21.75

22.19

20.65

19.05

18.28

ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT

9.32
26.05

6.85
26.77

5.86
26.77

8.30
26.77

10.71
26.66

9.94
26.66

16.56

17.63

17.63

17.63

17.56

17.56

9.49

9.14

9.14

9.14

9.10

9.10

ΔΔCT

-0.16

-2.29

-3.29

-0.84

1.61

0.84

TRADD gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B.
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control cells
and ceramide treated unifected cells (Cer) versus control cells
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A

FADD

B

Figure 33. Multiplex Real-time RT-PCR for FADD Gene Expression. FADD gene
expression (upper window) is normalized to GAPDH gene expression (lower window).
Following 1 hour ceramide treatment, there was no significant variation in gene expression
between sample types (Figure 33A). Two hour ceramide treatment demonstrates enhanced
gene expression for FADD (Figure 33B). Figure 33 is representative of multiple
independent experiments (n=3). Experimental samples were run in triplicate.

77

FADD Gene Expression
8.00

B+C vs Ctrl
Cer vs Ctrl

4.00

Cer vs B+C

Fold-increase

6.00

2.00

0.00
1 hr

1.5 hr

2 hr

3 hr

6 hr

12 hr

time

Figure 34. FADD Gene Expression. Gene expression is represented as relative fold-increase
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer)
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the
ΔΔCT method. Values represent the mean of the fold-increase. Enhanced expression levels
were described is determined to be statistically significant (p<0.05). Gene expression is
determined by multiple independent real-time RT-PCR experiments (n=3). Experimental
samples were run in triplicate.

Use of Non-treated Control Cells As Normalizing Samples In Apoptotic Gene Expression
Profiles
To generate a true baseline for gene expression in each of the experimental samples, we
compared the fold-increase in apoptotic gene expression for uninfected and infected cells to the
corresponding values for untreated uninfected and infected control cells (TRADD; Figure 39,
FADD; Figure 40, Caspase-8; Figure 41 and Caspase-3; Figure 42). Following treatment of
uninfected cells with ceramide, there was a significant increase in the expression of all four
apoptotic genes tested relative to untreated control cells (Tables 3C, 4C, 5C and 6C)
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Table 4. FADD Gene Expression Summary.
Cer vs
B+C
A

B+C vs
Ctrl
B

Cer vs
Ctrl
C

FADD
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT
ΔΔCT

1 hr

1.5 hr

2 hr

3 hr

6 hr

12 hr

1.63

3.87

3.98

4.84

0.89

0.98

0.09
26.27

0.50
27.67

0.08
27.30

0.95
27.10

0.08
27.57

0.38
26.57

16.86

17.67

17.99

17.38

17.68

17.13

8.70
25.65

8.06
29.32

7.68
29.87

7.46
28.11

10.06
29.10

9.53
27.81

29.75

21.26

22.19

20.65

19.05

18.28

9.15

9.42

9.02

9.25

9.36

9.05

-0.70

-1.81

-1.63

-2.26

0.17

0.09

FADD
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT
ΔΔCT

1 hr
0.92

1.5 hr
0.74

2 hr
0.66

3 hr
0.50

6 hr
0.48

12 hr
0.66

0.12

0.08

0.01

0.03

0.00

0.11

26.27

27.67

27.30

27.10

27.57

26.57

16.86

17.67

17.99

17.38

17.68

17.13

9.41
25.69

10.01
26.35

9.31
26.35

9.72
26.35

9.89
26.39

9.44
26.39

16.56

17.63

17.63

17.63

17.56

17.56

9.13

8.72

8.72

8.72

8.83

8.83

0.28

1.29

0.59

1.01

1.06

0.60

FADD
Fold-increase
STDEV

1 hr
1.37

1.5 hr
1.57

2 hr
2.13

3 hr
2.43

6 hr
0.43

12 hr
0.67

0.39

0.03

0.80

0.62

0.04

0.36

GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene
(Ref)
ΔCT

25.65

29.32

29.87

28.11

29.10

27.81

16.95

21.26

22.19

20.65

19.05

18.28

8.70
25.69

8.06
26.35

7.68
26.35

7.46
26.35

10.06
26.39

9.53
26.39

16.56

17.63

17.63

17.63

17.56

17.56

9.13

8.72

8.72

8.72

8.83

8.83

ΔΔCT

-0.43

-0.66

-1.04

-1.26

1.22

0.69

FADD gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B.
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control
cells and ceramide treated unifected cells (Cer) versus control cells
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A

B

Caspase-8

Caspase-8

Figure 35. Multiplex Real-time RT-PCR for Caspase-8 Gene Expression. Caspase-8
gene expression (A, upper window) is normalized to GAPDH gene expression (B, lower
window). Following 1 hour ceramide treatment, there was no significant variation in gene
expression between sample types (Figure 35A). Two hour ceramide treatment demonstrates
enhanced gene expression for Caspase-8 (Figure 35B). Figure 35 is representative of
multiple independent experiments (n=3). Experimental samples were run in triplicate.
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Caspase-8 Gene Expression
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Figure 36. Caspase-8 Gene Expression. Gene expression is represented as relative fold-increase
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer)
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the
ΔΔCT method. Values represent mean of fold increase. Enhanced expression described is
determined to be statistically significant (p<0.05).

In contrast, ceramide treatment has little or no effect on the expression of these genes in cells that
have been infected with B. henselae. These results strongly suggest that B. henselae infection
interferes with the expression of apoptotic genes.

Discussion
Real-time RT-PCR Assay Development
Microarray analysis and real-time RT-PCR both have the potential to generate large
amounts of information about gene expression. In general, microarrays are considered to provide
a more complete representation of cellular genome than real-time RT-PCR. However, the use of
microarrays would have raised significant difficulties under the experimental parameters we
employed.
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Table 5. Caspase-8 Gene Expression Summary.
Cer vs. B+C
A

Caspase-8
Fold-increase

1 hr

2 hr

3 hr

6 hr

12 hr

1.40

4.45

4.47

0.91

0.28

0.14
26.02

1.31
26.65

0.57
27.06

0.17
26.90

0.13
29.24

17.36

17.97

17.99

18.01

18.77

8.18
25.44
17.26

6.56
29.13
22.57

6.92
28.16
21.25

9.05
28.66
19.61

10.47
26.18
17.67

8.67

8.68

9.07

8.89

8.52

B+C vs Ctrl
B

STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene (Ref)
ΔCT
ΔΔCT
Caspase-8
Fold-increase

-0.48
1 hr

-2.11
2 hr

-2.15
3 hr

0.16
6 hr

1.96
12 hr

1.59

1.53

1.07

1.08

1.86

STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene (Ref)
ΔCT
ΔΔCT
Caspase-8
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene (Ref)
ΔCT
ΔΔCT

0.85
17.36

0.66
17.97

0.45
17.99

0.98
18.01

1.24
26.18

17.36

17.97

17.99

18.01

17.67

8.67
25.30
16.09

8.68
25.30
16.09

9.07
25.56
16.47

8.89
25.56
16.95

8.52
25.68
16.47

9.21

9.21

9.09

8.61

9.21

-0.54
1 hr
2.30

-0.53
2 hr
6.67

-0.03
3 hr
4.93

0.28
6 hr
0.95

-0.69
12 hr
0.44

1.62

1.23

2.61

0.87

0.26

25.44

29.13

28.16

28.66

29.24

17.26

22.57

21.25

19.61

18.77

8.18
25.30
16.09

6.56
25.30
16.09

6.92
25.56
16.47

9.05
25.56
16.95

10.47
25.68
16.47

9.21

9.21

9.09

8.61

9.21

-1.02

-2.64

-2.18

0.44

1.26

Cer vs Ctrl
C

Caspase-8 gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B.
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control
cells and ceramide treated unifected cells (Cer) versus control cells.
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B

Caspase-3

Caspase-3

Figure 37. Multiplex Real-time RT-PCR for Caspase-3 Gene Expression. Caspase-3 gene
expression (A, upper window) is normalized to GAPDH gene expression (B, lower window).
Following 1 hour ceramide treatment, there was no significant variation in gene expression
between sample types. Two hour ceramide treatment demonstrate enhanced gene expression for
caspase-3 (Figure 37B). Figure 37 is representative of multiple independent experiments (n=3).
Experimental samples were run in triplicate.
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Caspase-3 Gene Expression
8.00
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4.00

Cer vs Ctrl
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0.00
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time

Figure 38. Caspase-3 Gene Expression. Gene expression is represented as relative fold-increase
for ceramide induced B. henselae-infected cells (B+C), ceramide treated uninfected cells (Cer)
and control cells. Expression of apoptotic genes is normalized to GAPDH expression using the
ΔΔCT method. Values represent mean of fold increase. Enhanced expression described is
determined to be statistically significant (p<0.05). Gene expression is determined by multiple
independent real-time RT-PCR experiments (n=3). Experimental samples were run in triplicate.

For instance, the amount of RNA template required for microarray analysis, derived from in vitro
cell culture, would have been prohibitively large when considering multiple time points and other
experimental conditions that we had to address. Moreover, the addition of C2-ceramide, resulting
as it does in large-scale cell death of uninfected cells, would seriously affect the ability to isolate
RNA samples at levels high enough to analyze. To overcome these hurdles, real-time RT-PCR
was used as it requires substantially less RNA template. In addition to its ability to optimize
experimental parameters in ways that minimize the quantity of input template, real-time RT-PCR
can be conducted at significantly lower cost than microarray analysis. The robustness of a realtime RT-PCR assay is dependent on the design of the primer/probe set. Primer/probe sets were
designed using BLAST gene sequences available through GenBank.
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Table 6. Caspase-3 Gene Expression Summary.
Cer vs Ctrl
A

B+C vs Ctrl
B

Cer vs. B+C
C

Caspase-3
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT
GOI (Ref)
Norm Gene (Ref)
ΔCT

1 hr
1.71
0.19
23.61

2 hr
3.75
0.59
27.79

3 hr
2.65
0.28
26.73

6 hr
1.45
0.39
25.51

12 hr
1.10
0.52
25.21

17.26

22.57

21.25

19.61

18.77

6.36
23.21
16.09

5.22
23.21
16.09

5.48
23.35
16.47

5.90
23.35
16.95

6.44
22.92
16.47

7.12

7.12

6.88

6.40

6.45

ΔΔCT
Caspase-3
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)
ΔCT

-0.76
1 hr
1.25

-1.90
2 hr
0.79

-1.40
3 hr
0.92

-0.50
6 hr
1.43

-0.01
12 hr
0.76

0.61
23.78

0.39
25.07

0.32
25.03

0.86
24.46

0.47
24.10

17.26

22.57

21.25

19.61

18.77

-2.25

-1.58

-2.03

-2.45

-2.08

GOI (Ref)
Norm Gene (Ref)

23.21
16.09

23.21
16.09

23.35
16.47

23.35
16.95

22.92
16.47

ΔCT

-2.09

-2.09

-2.21

-2.21

-2.76

ΔΔCT
Caspase-3
Fold-increase
STDEV
GOI (Test)
Norm Gene
(Test)

-0.16
1 hr

0.51
2 hr

0.19
3 hr

-0.23
6 hr

0.68
12 hr

1.05
0.18
23.61

3.68
0.44
27.79

2.95
0.10
26.73

1.47
0.26
25.51

1.02
0.28
25.21

17.26

22.57

21.25

19.61

18.77

ΔCT
GOI (Ref)
Norm Gene (Ref)
ΔCT

1.17
23.78
17.36

0.38
25.07
17.97

0.52
25.03
17.99

0.87
24.46
18.01

1.30
24.10
17.67

6.42

7.10

7.04

6.44

6.43

ΔΔCT

-0.06

-1.87

-1.56

-0.54

0.01

Caspase-3 gene expression for ceramide treated unifected cells (Cer) versus ceramide treated B.
henselae-infected cells (B+C), ceramide treated B. henselae-infected cells (B+C) versus control
cells and ceramide treated unifected cells (Cer) versus control cells.
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TRADD

Figure 39. Multiplex Real-time RT-PCR for TRADD Controls. TRADD gene expression
(upper window) as compared to GAPDH gene expression (lower window). RNA templates
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. TRADD gene expression
demonstrates little variability in uninfected and non-apoptotic challenged cells at all time-points.
FADD

Figure 40. Multiplex Real-time RT-PCR for FADD Controls. FADD gene expression (upper
window) as compared to GAPDH gene expression (lower window). RNA templates
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. FADD gene expression across
a dynamic time-course demonstrates little variability in uninfected and non-apoptotic challenged
cells.
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Caspase-8

Figure 41. Multiplex Real-time RT-PCR for Caspase-8 Controls. Caspase-8 gene expression
(upper window) as compared to GAPDH gene expression (lower window). RNA templates
corresponding to 1, 4 and 12 hour ceramide-treatment time-points. Caspase-8 expression across a
dynamic time-course demonstrates little variability in uninfected and non-apoptotic challenged
cells.
Caspase-3

Figure 42. Multiplex Real-time RT-PCR for Caspase-3 Controls. Caspase-3 gene expression
(upper window) as compared to GAPDH gene expression (lower window). RNA templates were
generated from uninfected and untreated cells corresponding to 1, 4 and 12 hour ceramidetreatment time-points. Caspase-3 gene expression across a dynamic time-course demonstrates
little variability in uninfected and non-apoptotic challenged cells.
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BLAST sequences were used to design 5’-fluorogenic nuclease-assay primer and probe sets using
Primer ExpressTM software. The target primer and probe sequences were screened for crossreactivity using a silica-based system (courtesy of Lawrence Livermore National Laboratories).
Primer/probe sets were further scrutinized by searching for overlap and self-binding sequences
using Primer ExpressTM software. Lastly, primer and probe sequences were screened for near
match “hits” using “NCBI near query”. Primer and probe sequences that pass the software
vetting, were subject to testing by wet chemistry.
Each primer probe set was tested for its specificity, sensitivity and overall performance in
its ability to amplify the target gene. The proper ratio of primer/probe and cation concentration
ensures that the appropriate start amplification conditions are achieved (Figure 24). Each
individual primer/probe set may achieve optimal amplification with different cation
concentrations. Subsequently, the addition of any necessary supplemental components is
determined (Figure 25). It was previously demonstrated that multiplexed real-time PCR assays
exhaust reagents when target sequences are present at different molar concentrations. The
addition of Platinum TaqTM and additional dNTP’s is required for equal amplification efficiency
for target sequences (personal communication Dr. Jonas Winchell). The addition of supplemental
yeast tRNA was determined necessary to ensure RNA stability and reproducible data. tRNA acts
as a chaperone to stabilize RNA template and binds to the walls of plastic vessels ensuring that
target template is not adsorbed (Sambrook, 1989).
Further, titration of the primer/probes within the normal range was necessary to determine
the best minimal concentration without affecting signal intensity (Figure 26). Each gene marker
was then tested for its amplification efficacy (Figures 27-30). Multiplexed assays allowed for
assessing apoptotic genes while accounting for overall template concentration (Bustin and
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Nolans 2004). Properly vetting primer/probe sets allow for selection of the most favorable
primer/probe set for each target.
Use of Multiplexed Real-time RT-PCR to Assess Apoptotic Gene Expression
The major advantage of multiplexing the real-time RT-PCR assay is that it allows for the
assessment of multiple genes in context with a normalizing house-keeping gene in a single
reaction tube. Real-time RT-PCR has an added benefit in that it provides visual data for the
genetic sequence of interest without further manipulation. The dynamics of 5’-fluorogenic
nuclease chemistry adds an additional stringency to gene expression analysis by requiring two
primers (both forward and reverse) and a target specific probe. All three independent events are
necessary for generating a signal event. The lengths of real-time PCR amplicons are much shorter
than conventional PCR and therefore are inherently less likely to be affected by secondary
folding of synthesized product. The use of a single normalizing gene allows for relative gene
expression levels to be measured. However, relative gene expression is only an approximation of
true gene quantification (Suslov and Steindler, 2005).
Housekeeping Genes Used for Relative Apoptosis Gene Expression
Recently, there has been much debate about the use and reliability of conventional housekeeping genes for the purpose of normalizing gene expression. Some conventional housekeeping gene targets used for normalizing gene expression are: 18S ribosomal RNA, β-actin,
RNAase P and GAPDH (Goncalves et al., 2005). Much of this controversy stems from the
debate over the reliability of gene expression across different cell types (Radonic et al., 2004).
Gene expression analysis across multiple tissue types does require the use of normalizing genes
with low variability, but not necessarily robust expression. In addition, the use of multiple
normalizing genes is essential to properly standardize the basal expression when comparing
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different cell types (Vandesompele et al., 2002). However, our experimental model is a
homogenous stable cell line of a single cell type. This provides us genetic stability as opposed to
primary cells or hybrid cells used in previous research (Kirby and Nekorchuck, 2002). Further,
our interest focuses on analysis of a cluster of genes with complementary and non-competing
function. Lastly, we are assessing relative gene expression and not quantitative gene expression.
Due to the fact that we are using a homogeneous host cell model, the house-keeping gene
utilized herein provides a good reference for determining our best approximation of gene
expression. The use of multiplexed real-time RT-PCR has novel value in that we are assessing
the gene expression of a subset of desired genes between individual test and reference samples
using small quantities of RNA template derived from a small experimental sample.
Apoptotic Gene Expression
What does gene expression highlight about B. henselae’s intracellulat survival strategy?
When comparing gene expression for TRADD, FADD, Caspase-8 and Caspase-3, there are some
striking differences for cells that are infected with B. henselae as opposed to cells that are not.
TRADD expression is induced in a like manner for both ceramide-treated uninfected cells
(Cer) versus ceramide-treated B. henselae-infected (B+C) cells and Cer versus control (Ctrl) cells
(Figure 32). TRADD demonstrates a rapid increase in the earliest ceramide treatment timepoints
(1 and 2 hours), with a rapid decline thereafter, returning to baseline by 6 hours of ceramide
treatment. In contrast, TRADD gene expression for B+C versus Ctrl is below baseline for all
treatment time-points. The rapid induction of TRADD demonstrates that TRADD expression is
induced by the presence of ceramide. The fact that TRADD expression for B+C cells compared
to controls demonstrates that B. henselae is capable of suppressing TRADD gene expression
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following ceramide challenge. This is the first account of B. henselae’s ability to suppress the
synthesis of TNF-1 receptor-death-domain protein following challenge by an apoptogenic agent.
Unlike TRADD, FADD gene expression maintains a modest ubiquitous expression in
normal untreated cells. Following ceramide treatment, FADD increases from its normal
expression level, peaking at 3 hour post-ceramide treatment. FADD expression returns to
baseline thereafter. FADD expression appears to remain at baseline for B+C versus Ctrl during
the duration of ceramide treatment. The fold increase in FADD gene expression is most
impressive when comparing B+C versus Ctrl as compared to Cer versus Ctrl, where it appears
that the presence of B. henselae suppresses FADD gene expression below that of control cells.
This agrees with our preliminary finding that Western Blot analysis indicating that untreated
HMEC-1 cells infected with B. henselae suppress FADD protein expression (Chapter 2, Figure
7).
Following our observation that B. henselae infection has a demonstrable effect on
upstream TNF-dependent apoptosis modulators, we analyzed its effect on down-stream apoptosis
modulators. Caspase-8 gene expression was induced in a time-dependent manner for both Cer
versus B+C and Cer versus Ctrl (Figure 36). However, caspase-8 gene expression was observed
to be more pronounced in Cer versus Ctrl than for Cer versus B+C. This suggests that
intracellular B. henselae does suppress caspase-8 but not to levels below that of control cells.
However, B. henselae does suppress caspase-8 gene expression in the presence of an apoptotic
challenger.
Caspase-3 gene expression is consistent for Cer vs Ctrl and Cer vs B+C (Figure 36).
Caspase-3 gene expression peaks rapidly following ceramide treatment and wanes slowly
thereafter. The fold-increase of caspase-3 gene expression is modest at less than four-fold. In
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opposition to caspase-8, caspase-3 does target a multitude of cellular targets and has the most
abundant cellular pool and a long half-life of approximately 5.5 hours (Tan et al., 2006). The CT
value of caspase-3 is not significantly lower than that of caspase-8. It does not appear that the
presence of B. henselae has a dramatic effect on the gene expression of caspase-3, as compared
to TRADD or FADD. However, considering the cellular reservoir of caspase-3 protein and the
protein’s half-life, disrupting caspase-3 gene expression may not be an expedient strategy of an
intracellular pathogen.
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CONCLUSION

Role of This Study
In this study, we demonstrated that Bartonella henselae circumvents host cell apoptotic
mechanisms in order to survive as an intracellular pathogen of endothelial cells. B. henselae aids
in the survival of their host cells following direct apoptogenic stimuli, thereby aiding their own
intracellular survival. Previous researchers focused on the ability of B. henselae to stimulate host
cell proliferation via cellular growth modulators as the means of surviving apoptotic challenge
(Kempf et al., 2004; Maeno et al., 1999). Others concluded that B. henselae survive by
abrogation of apoptotic intrinsic pathway proteolytic enzymes to ensure intracellular survival
(Kirby and Nekorchuk, 2002). Recently, two groups claimed to have found the substrate
responsible for B. henselae’s ability to disrupt apoptosis (Kempf et al., 2005; Schmid et al.,
2006). Bartonella effector protein-A (BepA) has been described as the substrate that is
translocated to the host cell where it functions to block apoptosis by increasing cellular cyclicAMP (Schmid et al., 2006). However, other research utilizing BadA- B. henselae confirmed that
Bad A facilitates colonization of B. henselae and contributes a pre-formed effector molecule
found on both viable and non-viable B. henselae bacterial cells. The presence of this pre-formed
effector upregulates cellular inhibitor of apoptosis protein (IAP), which is regulated by NF-κB
(Kempf et al., 2005).
We assert that B. henselae achieve intracellular survival by redundant measures that
involve modulation of both extrinsic and intrinsic apoptotic pathways. Preserving host cell
viability is a consequence of infection with B. henselae, as well as with other related bacteria
(Conley et al., 1994). However, in contrast to previous research, we noted no significant increase
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in host cell proliferation due to the presence of B. henselae. It is possible that this effect of B.
henselae is not apparent within the time-frame of our experimental parameters. In addition, the
experiments described here did not reveal any effect of intracellular B. henselae upon
diminishing the cytotoxicity of RIP toxins (e.g., abrin and ricin) which have been shown to
induce apoptosis by caspase upregulation (Rao, P.V. et. al., 2005). Therefore, we conclude that
B. henselae is not capable of abrogating all apoptotic mechanisms. Instead, our research results
suggest that B. henselae exploits divergent apoptosis pathways to survive, such as suppression of
extrinsic pathway modulators TRADD and FADD, and suppression of intrinsic pathway caspase3 enzymatic activity. Bartonella’s tropism for endothelial cells is indicative of its evolution
toward host cells that are not induced to apoptosis by TNF-α (Faherty and Maurelli, 2008).

Gram-negative Bacterial Infection and LPS
The innate immune system is able to detect molecular patterns of most pathogens,
including lipoloysaccharide (LPS) of gram-negative bacteria. The molecular pattern of these nonmammalian molecules is recognized by Toll-like receptors (TLR) and CD14 (Hansson and
Edfeldt, 2005). LPS from Gram-negative bacteria bind to TLR-4 and CD14, which ultimately
leads to the release of IκB from the nuclear factor NFκB. Among the genes activated by NFκB is
TNF-α. Apoptosis induced by LPS from Escherichia coli in HMEC-1 cells was shown to be
FADD-dependent. However, neither TNF-R1 nor Fas receptor plays a role in E. coli LPSinduced apoptosis using HMEC-1 cells (Kyong-Bok et al., 1998). While E. coli LPS, which is a
potent pyrogen, effectively induces apoptosis in HMEC-1 cells, not all Gram-negative
endotoxins are apoptogenic.
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B. henselae possesses an LPS that lacks O-chain carbohydrates, much like other bacteria
capable of chronic infection such as Legionella spp. and Chlamydia. The result is that Toll-like
receptors-2 (TLR-2) are not activated and TLR-4 are activated at levels nearly 1000-10,000 fold
lower than that of other enteric bacteria (Zahringer et al., 2004). Gene expression triggered by
NF-kB causes ICAM-1 and E-selectin to be upregulated. However, in the case of B. henselae,
ICAM-1 and E-selectin are upregulated by the presence of a B. henselae synthesized
proteinaceous factor (Fuhrmann et al., 2001). It has been suggested that the lipid A component of
LPS can mimic the secondary messenger activity of ceramide. Using a cell permeable analog of
ceramide, such as C2-ceramide, induces many LPS-inducible genes (Barber et al., 1996; van
Bitterswijk et al., 2003).

B. henselae Infection
Nearly a quarter of a century ago, B. henselae was identified as the causative agent of catscratch disease (Wear et al., 1983; Slater et al., 1993). Transmission between cats occurs
horizontally through the arthropod vector Ctencephalides felis, the cat flea. Cats can maintain
persistent infections, however, transmission of B. henselae in a cat colony occurs by infection of
fleas from infected cats, which in turn infect other non-infected cats or re-infect a previously
infected cat (Breitschwerdt and Kordick, 2000). During the persistent B. henselae infection in
cats, the bacteria are harbored inside erythrocytes. Nearly 50% of domestic cats are seropositive
for antibodies to B. henselae. Cat to human infection occurs by exposure to B. henselae-infected
cat saliva or a scratch from an infected cat (Florin et al., 2008). Upon entering the human host, B.
henselae invade the hematopoetic progenitor cells but not erythrocytes. B. henselae have been
shown to infect macrophages (Musso et al., 2001; Kempf et al., 2005) and endothelial progenitor
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cells (Salvatore et al., 2008). This would provide a means for B. henselae to traffic from the site
of host introduction to their niche in the microvascular endothelium. B. henselae activate NF-κB
gene products during the course of binding to the endothelial cell membrane and the formation of
the invasome, a set of membrane protrusions that engulf the bacteria (Dehio et al., 1999).
However, invasome formation is found in umbilical vein endothelial cells such as HUVEC and
not microvascular cells (Dehio, 2004). Upon entry into the microvascular endothelium, B.
henselae induce the upregulation of cellular inhibitors of apoptosis (cIAP-1 and -2) and cellular
adhesion molecule genes, ELAM-1 and ICAM-1 (Faherty and Maurelli, 2008).

Bartonella Protein Factors and Their Role in Intracellular Survival
Bartonella possess a variety of genes that are analogous to pathogenicity factors used by
other bacteria that survive intracellularly in a similar manner (Foulongue et al., 2000). Some of
the proteins derived from these pathogenicity genes are used in an analogous manner to B.
henselae to ensure its survival (Hacker and Fischer, 2002). The VirB/D4 gene cluster was
discovered in Bartonella spp. following the identification of a 17kDa antigen with sequence
similarity to the virB7 gene of Agrobacterium tumefaciens (Padmalayam et al., 2000). Many of
the virulence properties of B. henselae, such as their entry into erythrocytic cells and their ability
to promote cytoskeleton and adhesion molecule rearrangement (Schulein et al., 2002), can be
ascribed to the expression of the VirB/D4 operon, which codes for a Type IV secretion system
(T4SS)(O’Callahan, et al., 1999). The induced operon functions to transfer Bartonella
translocated effector proteins (Bep A-G) into the host cells. BepA has been proposed to have
anti-apoptosis activity. Both BepA and BepD have also been proposed to have angiogenic
activity, while BepG has been assigned an anti-angiogenic role (Molloy, 2009; Scheidegger et
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al., 2009 ). BepA protein has been shown to translocate to the host cell membrane and increase
the cyclic adenosine monophosphate (cAMP) levels in the cell. cAMP then activates a variety of
protein kinases (PKA, ERK and MAPK) and inhibits the pro-apoptotic protein Bad. T4SS
substrates with similar function have been identified in other bacterial systems (Couturier et al.,
2006).
Although BepA appears to play a significant role as an anti-apoptotic factor, it is unlikely
that the BepA-induced pathway is the only mechanism used by B. henselae to prevent apoptosis
of their host. In many cases, pathogens have evolved redundant strategies to ensure their survival.
One example involves the F1 Yersinia antigen. Yersinia survival strategies and pathogenic
factors bear many similarities to those of Bartonella spp. and other intracellular bacteria (de Jong
et al., 2008). For many years, the F1 antigen has been considered to be the primary (and perhaps
only) factor necessary for Yersinia pestis pathogenesis. However, the recent isolation of virulent
F1 negative clinical isolates suggests that Y. pestis has other pathways available for maintaining
virulence (Bashaw et al., 2007; Dr. Jeanine Petersen CDC, Fort Collins, CO personnal
communication).
The B. henselae outer membrane protein adhesin A (BadA) has been identified as a
Bartonella pathogenicity factor required for pathogen and host cell interaction (Reiss et al.,
2004). BadA is a non-fimbrial adhesion protein similar to its Yersinia counterpart YadA
(Monack et al., 1997). BadA appears to play a role in initiating an angiogenic response in host
cells and inhibiting phagocytosis. However, a variant of the strain used for our studies (Houston1: ATCC 49882) lacks expression of BadA and yet is capable of adhesion and entry into
endothelial cells (Reiss et al., 2004). While the search for the conclusive pathogenicity factor of a
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particular pathogen is appealing, the reality is more likely to be that infectious agents have
devised a versatile repertoire in order to successfully survive (Rajashekara et al., 2005).

B. henselae Disrupts Gene and Protein Expression of Extrinsic and Intrinsic Apoptotic
Pathway Modulators Following Apoptogenic Ceramide Treatment
Our research has demonstrated that B. henselae targets apoptosis basically from the
outside in. In short, B. henselae is capable of disrupting apoptotic modulators that function
earlier in the cellular apoptotic pathway chain. Specifically, TRADD and FADD gene and protein
expression are disrupted by the presence of B. henselae. Past researchers have largely focused on
the enhanced proliferative activity of B. henselae factors as the mode of anti-apoptotic activity
(Kempf et al., 2001). Our studies differ in several ways. First, we used an experimental model
and growth conditions that are consistent with natural disease and maintain the integrity of
microvascular endothelial characteristics. In addition, we challenged the host cells with an
apoptogenic agent that mimics a natural cellular messenger in response to Gram-negative
bacteria.
We contend that serum starvation or protein synthesis inhibition (methods used by other
investigators to induce apoptosis) adds an unnecessary bias by suppressing protein synthesis. The
lack of serum simultaneously activates and suppresses multiple pathways and many of these
mechanisms are poorly understood. Further, low serum concentration causes HMEC-1 cells to
lose their microvascular endothelial characteristics (Ades et al., 1992). Protein synthesis
inhibitors provide two divergent biases. First, the lack of protein synthesis prevents any apoptotic
or anti-apoptotic gene product which lacks sufficient cytoplasmic pools from being generated.
This is not consistent with primary mechanisms of the natural disease state or the host immune
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response. Secondly, previous researchers have demonstrated that protein synthesis inhibition
disrupts the balance between typical caspase and c-FLIP proteins (Zimmermann et al., 2001).
Two apoptogenic agents which indeed disrupt protein synthesis, ricin toxin and abrin toxin, were
tested in our model. The apoptogenic effect of these two agents on the host microvascular
endothelial cell was not disrupted by the presence of B. henselae (data not shown).
The use of ceramide affords us an apoptogenic agent that mimics the cellular response to
Gram-negative LPS (van Bitterswijk et al., 2003). Ceramide has been characterized as causing
induction of cellular kinases which leads to caspase induction in several experimental models. In
fact, ceramide functions in at least four areas of the cell during apoptosis signaling. In the Golgi,
ceramide contributes to lipid metabolism which helps generate lipid rafts (van Blitterswijk et al.,
2003). At the cell membrane, ceramide facilitates receptor clustering (Gulbins et al., 2004), and
alters mitochondria permeability (Kolsenick, 2002; Siskind et al., 2002). Ceramide also
contributes to the formation of membrane bound apoptotic bodies (van Blitterswijk et al., 2003).
Ceramide is released endogenously following extracellular stresses, such as treatment with
lipopolysaccharide (LPS). However, we confirmed what others have observed that, B. henselae
LPS is not cytotoxic by comparing the cytotoxic effect of like concentrations of endotoxin
derived from both B. henselae and E. coli (Zahringer et al., 2004). We have demonstrated that
endothelial cells respond to exogenous ceramide in a dose-dependent apoptotic response.

B. henselae Disrupts Extrinsic Pathway Receptor Mediated Apoptosis in Order to Ensure
Its Survival
TNF-receptor-1 (TNF-R1) clustering induces recruitment of TRADD to the TNF-R1
death domains (DD). This occurs in response to TNF-α-induced receptor clustering or lipid raft
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induced clustering. In endothelial cells, the endogenous release of TNF-α would not necessarily
signal theTNF-R1 clustering that would be expected to result in DISC formation. However, the
addition of exogenous ceramide is known to result in lipid raft formation and the clustering of
receptor proteins (Cuschieri et al., 2006; Gulbins et al., 2003). The clustering of TNF-R1 by
ceramide would induce DISC formation, resulting in the accumulation of TRADD at the TNF-R1
DD. The recruited TRADD would recruit necessary downstream modulators (e.g., FADD). The
rapid rise and fall of TRADD gene expression for ceramide treated endothelial cells would
indicate that either 1) TRADD is stable and does not require prolonged translation,or 2) as the
uninfected cell succumbs to ceramide treatment, the cell is diverting valuable resources to the
production of new TRADD proteins. Infection by B. henselae precipitously suppresses both gene
and protein induction of TRADD, indicating that there is a strong correlation between the
presence of the bacteria and the signal(s) that trigger TRADD induction. By suppressing TRADD
gene expression, B. henselae could cut off the cascade of events associated with the TNF-R1
extrinsic apoptosis pathways.
TRADD and FADD are sequential cellular modulators recruited by TNF-R1 in the TNFdependent pathway. FADD recruitment has already been demonstrated to induce endothelial cell
apoptosis specifically in HMEC-1 cells (Kyong-Bok et al., 1998). As mentioned previously, our
early observation that FADD protein expression declines following B. henselae infection
suggested a preemptive and continuous anti-apoptotic strategy by B. henselae. It is important to
remember the loss of detectable FADD by Western Blot following infection of B. henselae
(Figure 7) occurred in the absence of any apoptosis agonist. The overall purpose of FADD in
extrinsic pathway apoptosis is the recruitment of other downstream apoptotic modulators, namely
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caspase-8, to the DISC. FADD is recruited by both TRADD and Fas as part of extrinsic apoptotic
signaling pathways.
When examining gene expression as fold-increase, it is important to point out that
expression levels are based on which sample type is being used as the benchmark and which is
used as the illustration. Gene expression for TRADD is profoundly induced by ceramide. This is
potentiated by the fact that the presence of B. henselae suppresses TRADD gene expression.
FADD gene expression is only modestly induced by ceramide. B. henselae-infected cells
suppress FADD gene expression, which makes FADD appear as a highly inducible gene
following ceramide treatment. A different picture emerges when analyzing TRADD and FADD
protein expression. TRADD protein expression is clearly inducible and is suppressed by the
presence of B. henselae. The percentage of cells expressing TRADD is nearly 3 times lower in B.
henselae-infected cells. Conversely, FADD protein is expressed in nearly half the cells regardless
of B. henselae’s presence. But the presence of B. henselae does keep FADD expression from
going any higher and slightly suppresses FADD protein expression. We demonstrated that B.
henselae affects FADD protein expression both during the course of infection or following
apoptogenic stimuli of B. henselae-infected cells. What is more pronounced is the profound
effect B. henselae has on the gene and protein expression of TRADD. By abrogating TRADD
signaling, B. henselae has subverted initiation of an entire apoptotic pathway.

B. henselae Suppresses Caspase-3
Previous studies have indicated that Bartonella-infected cells suppress apoptosis
induction by abrogating caspase activity (Kirby et al., 2002). Our data indicate that B. henselae is
capable of suppressing caspase-3 activity and caspase-8 and -3 gene expression. But the loss of
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caspase-8 activity was not observed within our experimental parameters. Caspase-8 is the initial
cysteine protease messenger in extrinsic (TNF-receptor-1 and Fas-dependent) apoptotic signaling
pathways. Pools of capase-8 are maintained in the endoplasmic reticulum and translocated to the
DISC complex following receptor signaling (Homlstrom et al., 2000). As an initiator of the
caspase cascade, caspase-8 present at high levels is not sufficient, nor required, to sustain
apoptotic induction (Green, 2003). As an executioner, caspase-3 proteolytically cleaves many
cellular substrates. Additionally, caspase-3 is necessary as an executioner for both intrinsic and
extrinsic apoptotic pathways. This would require that either large pools of caspase-3 are
maintained, or that caspase-3 is a rapidly inducible gene product. As mentioned earlier, caspase-3
is the most abundant caspase in the cell (Chickova et al., 2004).
It is worthy to note the inherent flaws in relying upon caspase proteolytic activity assays
as a true measurement of caspase involvement. First, the caspase specific target peptides are not
actually specific, but rather preferential for a particular caspase. Second, enzymatic activity may
not be an accurate measurement of a specific caspase activity. Historic dogma asserts that
caspases are synthesized in a proform. The active “enzymatic” form is generated following
proteolytic cleavage. Recent studies refute that assertion, especially with regard to caspase-8.
Caspase-8 is active in its dimeric form (Green, 2003; Thorburn et al., 2004). As mentioned
earlier, caspase-8 has been shown to be “enzymatically” active in an unprocessed form. Thus,
unprocessed caspase-8 may facilitate auto-proteolysis of caspase-3. Unlike caspase-8 and
possibly caspase-6, caspase-3 is primarily a proteolytic enzyme.
What is clear is that ceramide treatment causes activation of caspase-3. Ceramide-induced
activation of caspase-3 for uninfected cells occurs earlier, is maintained for a longer duration and
is significantly more active as compared to ceramide treated B. henselae-infected, or control
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cells. Our observation that caspase-3 is the only caspase of those we tested that is suppressed by
the presence of Bartonella species is in direct conflict with previous observations (Kirby and
Nekorchuck, 2002; Schmid et al., 2006). We believe this is in part due to the cell line model
used. Cell type variability in the use of different apoptosis mechanisms is an obstacle when
comparing results using different model systems. Additionally, the use of an apoptogenic agent
may produce different results than the use of serum starvation as the apoptogenic stimulus.

Summary
What we know about the strategies used by B. henselae to maintain host cells in numbers
sufficient for successful infection is multifaceted. Previous research has demonstrated that B.
henselae enhances proliferation (Slater et al., 1994; Maeno et al., 1999), that the cell
cytoskeleton is rearranged during the course of infection (Dehio, 1999) and that adhesion
molecules are upregulated that enhance B. henselae internalization (Fuhrmann et al., 2001).
Additionally, unlike those of other Gram-negative bacteria, the LPS molecules of B. henselae are
not capable of inducing apoptosis (Zahringer et al., 2004). The VirB/D4 operon provides a
transport pilus that acts to translocate effector proteins, such as BepA, which are capable of
“subverting” the host cell apoptosis mechanisms. Moreover, B. henselae generated modulators
can affect caspase activity and thereby influence the cells’ decision to enter an apoptotic pathway
(Schmid et al., 2006).
Our research provides evidence that B. henselae disrupts host cell gene and protein
expression of the extrinsic apoptosis modulators TRADD and FADD. TRADD gene expression
in particular is significantly suppressed by the presence of B. henselae. B. henselae also
suppresses FADD gene expression. FADD protein is ubiquitously expressed under normal
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cellular growth conditions. However, the presence of B. henselae minimizes FADD protein
expression even following prolonged apoptogenic stimuli. In our experimental system caspase-8
and caspase-3 gene expression were modestly suppressed by B. henselae.
The proteolytic activity of either caspase-8 or caspase-6 was unaffected by the presence of
B. henselae. However, the proteolytic activity of caspase-3 was suppressed significantly B.
henselae. In fact, at some ceramide treatment time-points, B. henselae-infected cells had higher
caspase-6 and caspase-8 activity than their uninfected counterparts. Lastly, the formation of
apoptotic bodies and DNA fragmentation was dramatically reduced in B. henselae-infected cells.
Enhanced host cell viability for B. henselae-infected cells was consistent with these results. We
do know that B. henselae cannot disrupt the apoptogenic action of all apoptogenic stimuli, such
as ricin and abrin toxins.

Future Directions
The means by which B. henselae migrate from their point of entry to their niche in the
microvascular endothelium is not understood. Furthermore, the cellular proteins targeted by
translocated effectors upon entry by the bacterium into the microvascular endothelium remain to
be identified. Only a handful of apoptogenic agents have been used to challenge Bartonella spp;
Hundreds of natural apoptogenic agents remain untested. Still, elucidation of the mechanism(s)
by which B. henselae ensures its survival will enhance our understanding of pathogen-induced
tumorgenesis. It will also help us to understand the processes used by evolutionarily similar
intracellular bacterial pathogens.
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